<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1000083763474443&amp;ev=PageView&amp;noscript=1">

SmartTRAK Life Sciences News and Analysis Blog

10 min read

MedTech Innovation in the Time of COVID

By Thomas Wallick on 8/11/20 8:00 AM

Despite the unprecedented challenges of the ongoing pandemic, and the collateral economic hit taken due to the massive decline in elective procedures in Q220, MedTech companies continue to innovate and introduce new products to the global life sciences industry.

The following is just a small sampling of the new products updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, financial data and competitor developments in the global Life Sciences industry.

In Q220, Alphatec commenced upgrades of its cervical portfolio with 510(k) clearance of the Insignia Anterior Cervical Plate System and InVictus CT Spinal Fixation System, which expands InVictus across cervical, thoracic and lumbar procedures.

GMED has launched 6 new products in 2020 w/ strong uptake of HEDRON 3D printed IBD spacers as well as SABLE expandable MIS TLIF device. Globus is doubling its 3D manufacturing capacity which should come online in Q4. GMED Q220 Earnings Transcript on Seeking Alpha

Alpha launches for COHERE TLIF O and TLIF A are slated for 2020, expanding the Company’s proprietary porous PEEK platform. NUVA Q220 Earnings Transcript on Seeking Alpha

Topics: COVID-19
Continue Reading
2 min read

Spine Market COVID-19 Update: Quick Rebound?

By Julianne Burns on 8/6/20 9:30 AM

The latest intel suggests the spine market is rebounding more quickly than expected, but certain new market dynamics will persist.

While much remains up in the air, early data suggests the spine market is rebounding more quickly than expected. Surgeons are beginning to perform cases that were postponed through March and April due to COVID-19. In conversations with WFS analysts,  NuVasive* (NUVA) management reported a mix of both deferred cases and new volume in May. NUVA’s spine business reportedly tracked ~50% below pre-COVID levels in May versus ~70% below in April. The Company’s current trajectory and consensus expectations for the quarter implies a recovery in procedure volumes to 35% below pre-COVID levels in June according to  WFS NUVA: Takeaways From The 2020 “Virtual” Bus Tour Report. Similarly, Canaccord Genuity estimates  Alphatec’s* FY20 US revenue will be down –9.7% YoY with an estimated -45.6% drop in Q220 sales. This assumes the impact from COVID-19 started in mid-March, April revenues were down ~60-70%, and notable improvement began in early May as more states resume procedures.
Topics: Orthopedics
Continue Reading
8 min read

International MedTech News Updates: The Week in Review

By Thomas Wallick on 8/4/20 8:40 AM

The unprecedented challenges from the current resurgence of COVID-19 cases worldwide continues to concern the MedTech industry as it strives to develop ways to deal with a post-pandemic world. Despite the struggling global economy, demand for innovative medical devices and advanced technologies will continue to drive long term growth.
 
The following is just a small sampling of the updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.
 
June in Russia

In the pharmacies in Russia, commercial drug June sales increased by 0.1% in value vs May 2020. Compared to June 2019, sales increased by 2.1%. The increase in the first 6 mos in 2020 was 13.9% vs the same period in 2019.

Teleconsultation in France

During the lockdown in April, 27% of all consultations were teleconsultations in France. Of doctors carrying out teleconsultations, 50% were under 50 yrs old, though that age group represents only 37% of all GPs.

MedTech World in Germany

MedTech companies in Germany expect sales to decline an avg of 8% in 2020 due to the pandemic, including 12% in int’l business according to a survey. Almost 60% of companies expect a double-digit drop.

Continue Reading
3 min read

Stroke Care During an Evolving Pandemic: An Interview with J Mocco, MD

By Anne Staylor on 7/30/20 11:29 AM

J Mocco, MD, MS discusses how an evolving pandemic is affecting stroke care in an interview with SmartTRAK

The COVID-19 pandemic has dramatically disrupted health care around the world and is wreaking havoc on medical device markets. In the US, social distancing and other mitigation efforts have helped flatten the curve and many states are now working toward reopening their economies.

The pandemic continues to evolve and its impact on healthcare delivery systems is rapidly changing. Elective surgery has re-started again in many states and hard-hit places like New York City have seen COVID-19 cases peak and start to trend downward. So how are these trends affecting stroke care? Why are strokes up in some regions but down in others? When will neurointerventional procedure volumes return to pre-COVID levels? To find out the answers to these questions and more, SmartTRAK talked with J Mocco, MD, MS, Vice Chair, Department of Neurosurgery and Professor of Neurosurgery at Mount Sinai Health System in New York City.

To listen to the interview recorded via Uberconference on Monday May 11, click on the following video. A transcript of the interview can be downloaded here.

Continue Reading
5 min read

SAWC Spring 2020 Goes Virtual: The Week In Wound Care

By Thomas Wallick on 7/28/20 7:53 AM

As the COVID-19 continues to affect every aspect of life, the MedTech industry perseveres in its attempt to adapt and continue moving forward. SAWC and the Wound Healing Society held the SAWC Spring 2020 as a virtual experience on July 24-26. In their words "At a time when so much else is canceled, the work to treat, manage, and prevent chronic wounds and improve patient care cannot stop. Hope must go on."

The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts, including many from SAWC 2020. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.

COVID-19 and Chronic Wound Patients

Dr. Margaret A Liu, an expert in vaccines and immunotherapies, provided an excellent presentation on the intersection of vaccine technologies for COVID-19, disease pathology for pts w/ chronic wounds, and how it fits together with a global pandemic. SAWC 2020 Virtual

Topics: Wound Care
Continue Reading
3 min read

SmartTRAK Analysts Featured in Cartilage.org ICRS Newsletter

By Thomas Wallick on 7/24/20 1:18 PM

SmartTRAK, the leading source of competitive intelligence used by the top global orthopedic & wound care companies, had four articles featured in the International Cartilage Regeneration & Joint Preservation Society Summer 2020 Issue. These articles were originally published on the SmartTRAK platform.

The ICRS is the main forum for international collaboration in cartilaginous tissue research and joint preservation whose stated mission is "Advancing Science & Education of the Prevention & Treatment of Cartilage Disease Worldwide."

Kim French, SmartTRAK's Senior Analyst, OrthoBio, had three of her articles included in the Summer 2020 issue:

Continue Reading
6 min read

Double Whammy Impacts Strong Start: Q120 Computer Assisted Surgery Spine Mkt

By Elise Wolf on 7/22/20 9:31 AM

Strong start in Q120 was negatively impacted by the double whammy of postponed elective procedures and lag in capital equipment purchases as the result of the COVID-19 pandemic.

While adoption of robotics and other enabling technologies was gaining significant momentum quarter over quarter through year-end 2019, delays in elective spine surgery due to the COVID-19 pandemic resulted in declines in capital equipment sales and fewer computer-assisted spine surgeries in Q120. However, these declines are expected to be temporary and improve as surgeries rebound through the end of the year and into 2021.

Among the many topics covered in the comprehensive Q120 CAS Spine Market Recap* are:

Topics: Orthopedics
Continue Reading
8 min read

Recovery Predictions, Elective Surgery and Future Outbreaks: COVID-19 Updates

By Thomas Wallick on 7/20/20 1:40 PM

As the COVID-19 pandemic progresses and continues to affect everyday life around the world, the path that lies ahead for the MedTech industry and the search for effective therapeutics and vaccines remains hard to predict.

The following is a small sampling of the updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor  the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.

SVBLeerink Expects Q2 Recovery to Exceed Expectations 
Based on prelim Q220 MedTech Company results, SVB Leerink expects May/June COVID recovery to exceed expectations noting elective procedure shutdowns are regionalized and halts are not expected to be as bad or prolonged as in March/April. SVBLeerink Medical Supplies and Devices
 
Positive COVID-19 Vaccine Data Could Fuel Medtech Sectors

With 4 of the leading vaccine candidates expected to enter Phase 3 studies in July (Sinovac, Moderna, BioNTech/PFE, CanSino), Phase 2 data could be reported in summer/fall 2020. If +, WFS says it could be a catalyst for some medtech sectors in recovery of elective procedures.

Public Perception of Resuming Elective Surgery

A survey assessing public perceptions towards resuming elective surg found out of 722 people 61% were concerned w/ contracting COVID-19 during surg. Overall, 57% would have surgery at a hospital vs outpatient and 27% would undergo surg in the first mo of reopening. J Arthroplasty

Preparation for Future Outbreaks

The European Commission published a document about the preparedness of health systems in Europe for future COVID-19 outbreaks. Topics comprise testing, contact tracing, surveillance, accessibility of medical devices and capacity measures.

Continue Reading
6 min read

Q120 Computer Assisted Surgery Ortho Revenue Hit with 1-2 Punch

By Elise Wolf on 7/16/20 10:12 AM

 

Companies came out of the gate strong in Q120, but COVID-19’s one-two punch on elective procedures and capital equipment purchases negatively impacted orthopedic enabling technology revenues toward the end of the quarter.

While adoption of robotics and other enabling technologies was gaining significant momentum quarter over quarter through year-end 2019, delays in elective spine surgery due to the COVID-19 pandemic resulted in declines in capital equipment sales and fewer computer-assisted orthopedic surgeries in Q120.

Among the many topics covered in the comprehensive Q120 CAS Ortho Market Recap* are:

Continue Reading
9 min read

Novel Ideas, New Products and Innovative Studies: The Week in OrthoBio

By Thomas Wallick on 7/14/20 8:00 AM

The orthobiologics market continues to ramp up studies and new product development as surgeries impacted by COVID-19 are rescheduled. The following is a small sampling of the OrthoBio updates compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor  the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, financial data and competitor developments in the global Life Sciences industry.

KAPPA Opiod - Possible DMOAD? 

KECK Medicine of USC has published a preclinical study demonstrating the potential of a new opioid medication that may slow OA progression while being less addictive. The therapy MOA is kappa opioid receptor (KOR) modulation via inhibition of hedgehog signaling. Arthritis Rheum

Association of SNPs in MMPs Genes and Knee OA

A 200-pt prospective, case-control study is underway to assess if the presence of gene polymorphisms (1575 G/A MMP-2, 836 A/G MMP-9 and -77 A/G MMP-13) in the metalloproteinases (MMPs) affect the risk of developing idiopathic kOA in the Greek population. clinicaltrials.gov

National Rates and Risk Factors of Failed Primary RCR

An insurance database review w/ 41,467 primary RCR pts (41,844 shoulders) showed 52.7% male, 60-69 yrs of age most prevalent (~38%) and 8.38% revision rate. Revision risk factors were increasing age, male sex, smoking, obesity, hyperlipidemia and vitamin D deficiency. Arthroscopy

Continue Reading
4 min read

Back Down the Revenue Track: Q120 Soft Tissue Fixation Market Recap

By Freddy Buntoum on 7/10/20 10:37 AM

A well-oiled engine, the Soft Tissue Fixation train was prepped for a good start to 2020, then COVID-19 sent it in reverse back down the revenue tracks.

Looking back at how 2019 finished, market sentiment was quite optimistic that 2020 could be another positive year for the WW Soft Tissue Fixation Market. With +3.7% YoY growth in Q419, the first quarter of 2020 seemed set for a good start, with companies chugging along nicely, actively pushing products, planning or recruiting for clinical trials, and some of them also receiving FDA 510(k) clearance for new products or for line extensions. All appeared to be business as usual, that is, until COVID-19 reared its ugly head, picking China as its first target. Alas, the rapid worldwide spread of this devastating virus forced a major halt in elective procedures to enable healthcare systems to focus on the rising number of COVID-19 cases. 

Among the many topics covered in the comprehensive Q120 Soft Tissue Fixation Market Recap* are:

Continue Reading
5 min read

Treading Water: Q120 US Surgical Matrices Market Recap

By Doug Devens on 7/9/20 10:21 AM

The US Surgical Matrices Market treaded water in Q120, up +1.6%, as the impact of COVID-19 began to be felt broadly at the end of a quarter that had initially started with good growth.

In Q120, the US Surgical Matrices Market grew +1.6% YoY according to BioMedGPS’ SmartTRAK Financial Dashboard. Allergan* maintained its lead despite the slowdown in breast augmentation and reconstruction surgeries due to COVID-19, gaining +3.4% YoY. Becton Dickinson* (BD) also had been growing well until COVID-19 slowed hernia surgeries, and, like many other companies, warned that Q220 would be far worse since the impact of COVID-19 would be felt at the beginning of the quarter.

Among the many topics covered in the comprehensive Q120 US Surgical Matrices Market Recap* are:

Topics: Wound Care
Continue Reading
7 min read

Mid-March Madness of COVID-19: Q120 OrthoBio Market Recap

By Kim French on 7/8/20 9:30 AM

The mid-March madness of COVID-19 results in final missed shots for many companies.

For sports fans, March is about celebrating the best in college basketball. Regrettably, March Madness was swapped with COVID-19 mid-March madness, disrupting lives and companies across the world. Since the COVID-19 outbreak, the first corporate earnings season has concluded and we now have a peek of the negative impacts caused by the pandemic and deferral of elective procedures. As for Q120, US orthobiologics revenue declined -5.5% YoY compared to Q119. 


Among the many topics covered in the comprehensive 
Q120 OrthoBio Market Recap* are:

Continue Reading
6 min read

COVID-19 Surges: The MedTech Industry Reacts

By Thomas Wallick on 7/6/20 4:35 PM

As COVID-19 surges in the United States and around the world, health officials are responding with stern warnings, more testing and cutbacks on closings. While some nations have virtually stopped the spread within their country, MedTech prepares for a post-COVID world and how the virus and the response to it will reshape the industry.

The following is a small sampling of the COVID-19 updates compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers:

Study Projects COVID Impact on US Healthcare

A statistical analysis study concluded elective procedure deferment during the COVID-19 pandemic will have a lasting impact on the US healthcare system and could result in a cumulative backlog of > 1MM ortho surgical cases at 2 years after the end of surgery deferment. JBJS

Challenges when Restart in the UK

A report w/ the title of ”Getting the NHS back on track: planning for the next phase of COVID-19” was published in the UK by the NHS Confederation. The paper talks about the 7 challenges of the health care system when restarting the health care services in the UK.

Canaccord Sees Upside to H220

Canaccord feels SNN’s Q220 preliminary results suggest better-than-expected improvements and an upside to H220 estimates. Canaccord feels US states/health systems are better positioned to handle COVID cases and doesn’t expect widespread elective procedure restrictions.

Continue Reading
5 min read

Positive Growth in Q120: Infection Prevention Vascular Access Recap

By Susan Paquette on 7/2/20 10:15 AM

Q120 remained a bright spot showing positive growth with modest disruption from COVID-19 for the quarter.

For Q120, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market was up +4. 4% YoY. The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Among the many topics covered in the comprehensive Q120 Infection Prevention: Vascular Access Adjunct Products Recap Market Recap* are:

Topics: Wound Care
Continue Reading
6 min read

Hemostats and Sealants Up Despite COVID-19: Q120 Market Report

By Doug Devens on 7/1/20 10:24 AM

The US market for Hemostats and Sealants grew +6.1% YoY in Q120, up from the pace of Q419 despite the late appearance of COVD-19 in the last few weeks of the quarter. Growth was slightly higher in the Hemostats market, with +6.8% growth driven by relative strength in thrombin hemostats.

As reported in SmartTRAK Financial Dashboard, the US Hemostats and Sealants market had a growth rate of +6.1% in Q120. Leading the way in Q120 was Baxter* with +11.6% YoY growth and continued strength from Tisseel* and Artiss* fibrin sealants. Becton Dickinson* (BD) also posted strong gains as its relaunched Progel* and continued its resurgence in Q120. However, all manufacturers predicted that second-quarter results would be much worse since the full effect of surgery deferrals would be felt for the entire quarter. Some manufacturers warned that revenues were reduced as much as...

Among the many topics covered in the comprehensive Q120 Hemostats and Sealants Market Recap* are:

Topics: Wound Care
Continue Reading
7 min read

COVID-19 Slows SCS Market Momentum: Q120 Market Recap

By Anne Staylor on 6/30/20 11:00 AM

The SCS market saw double-digit declines in Q120 as elective procedures fell off a cliff toward the end of the quarter due to COVID-19

After a disappointing slowdown in 2019, the spinal cord stimulation (SCS) market was positioned for growth in Q120 after a successful North American Neuromodulation Society (NANS) Annual Meeting in January 2020. With new data and products providing an early tailwind for all SCS competitors, companies reported positive momentum until approximately the third week of March when COVID-19 led to shelter-in-place orders and a sharp decline in elective procedures. This effectively put a halt to the vast majority of SCS trials and implants in the US and also impacted companies with SCS sales in China during January and February ...

Among the many topics covered in the comprehensive Q120 Spinal Cord Stimulation (SCS) Market Recap* are:

Continue Reading
5 min read

International Medtech News Roundup: Updates from Around the Globe

By Thomas Wallick on 6/29/20 9:18 AM

As the international response to COVID-19 shifts to preparing for a potential second wave, the Medtech industry pushes forward with the development and approval of new devices. The following is just a small sampling of the past week's international updates that were curated, compiled, reviewed and posted throughout the day by the expert analysts at SmartTRAK. They sift through the noise to discover the latest international news, industry trends, financial data and competitor developments in the global Life Sciences industry.

Pandemic Reserve in Germany

In Germany, as a result of the past months, BVMed proposed to the Minister of Health to build stock for masks and protective equipment for 6 months to be used in pandemics.

How To Build Wound Care Knowledge

The Odense University Hospital in Denmark built up a blended learning concept in wound care for nurses to support them in gaining confidence when carrying out wound care. E-learning modules, study visits and workshops are mixed to address the needs.

Medical Device Promotion in France

In France, The National Agency for the Safety of Medicines and Health Products (ANSM) published a guideline on how advertising visas should be handled for medical devices during the state of emergency (until July 10, 2020) and through the year.

Restricted China Export Boost Local Market

Freight costs have increased dramatically during the COVID-19 outbreak. Chinese medical dressing export are mainly low cost, less advanced dressings. Manufacturers are now looking more to grow sales on their local China market, to replace imported more advanced dressings.

Continue Reading
5 min read

Q120 Trauma Market Growth Halted Mid-March by COVID-19 Pandemic

By Natasha Weeks on 6/25/20 9:30 AM

COVID-19 halts the Trauma Market’s Q120 growth, leading to a -2.8% YoY decline globally.

Q120 was tracking as a stable quarter for the US Trauma Market, following Q419’s +3.8% growth, however, this was interrupted in mid-March by the COVID-19 pandemic. The US Trauma Market was down -1.2% YoY for the quarter, with WW revenues declining -2.8%. The non-elective trauma market experienced a reduction in trauma admissions due to the decrease in daily activities and limited driving for most of the US.

Among the many topics covered in the comprehensive Q120 Trauma Market Recap* are:

Topics: Orthopedics
Continue Reading
6 min read

The Week in Neuromodulation: New Clinical Trials and Devices

By Thomas Wallick on 6/23/20 8:30 AM

This week, our expert analysts have sifted through the noise to present some of the latest product developments and clinical trials from the Neuromodulation industry. At SmartTRAK,  our analysts constantly monitor the worldwide MedTech industry to present real-time news, analysis and financial data. All of our analysts are experts in their field, having worked in business development, marketing and competitive intelligence roles at leading medical device companies.

The following is a small sampling of Neuromodulation segment updates from the past week that were compiled, reviewed and posted throughout the day by the industry-experienced analysts at SmartTRAK:

Mainstay Medical Receives FDA Approval for ReActiv8 System

Mainstay Medical rec’d FDA approval 6/16/20 for the ReActiv8 System indicated for stimulation of the L2 medial branch of the dorsal ramus for intractable CLBP assoc. w/ multifidus muscle dysfunction. Chris Gilligan, MD-INS Webinar: Novel Stimulation Technologies-Recent Research.

Non-Invasive VNS for PTSD and Mild TBI

The VA is sponsoring a 100-pt, double-blinded study evaluating the effect of non-invasive VNS (nVNS) vs sham on memory and symptoms of PTSD and mild TBI (mTBI) as well as brain and physiology in veterans w/ mTBI and PTSD. The study starts 8/1/2020. clinicaltrials.gov

Rice-Sized Neural Stimulator for DBS

Rice University researchers demonstrated that a miniature, wireless magnetically powered neural stimulator (> 100 Hz) can provide DBS in a rodent model for Parkinson’s disease and that these devices can be miniaturized to millimeter-scale and fully implanted. Neuron

Continue Reading
5 min read

Advanced Wound Care Posts Modest Gains Offset by China: Q120 Market Recap

By Susan Paquette on 6/22/20 11:22 AM

In Q120, the US and EU AWC markets experienced modest gains, offset by ROW (China) hit early in the quarter with COVID-19.

For Q120, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +2.2% YoY. Many companies commented on the impact of COVID-19 on their business performance. Overall, the impact in Q120 was limited, as the pandemic hit in March in most countries, whereas Jan and Feb were more business as usual. All are expecting a more severe impact in Q220, and almost all companies have withdrawn their FY20 projections.

Among the many topics covered in the comprehensive Q120 Advanced Wound Care Market Recap* are:

Topics: Wound Care
Continue Reading
6 min read

Spine Market Derailed Due to Covid Impact: Q120 Market Recap

By Julianne Burns on 6/18/20 11:01 AM

Spine’s solid start to Q120 was derailed in March by COVID-19, leading to a -10.6% YoY decline globally.

Q120 reporting gives us the first glimpse into the effect of COVID-19 on the spinal hardware market, with the impact in the US felt starting in mid-March. A multi-dimensional survey of 902 spine surgeons around the globe revealed that 67.1% of respondents saw the cancellation of greater than 75% of their surgical cases per week in late March/early April. Global Spine J.

The WW Spine Hardware market experienced a -10.6% downturn in the quarter, with the US down -11.2%. Several companies noted they were tracking for strong Q1 growth prior to the pandemic. At the end of February, SeaSpine* reported that it was looking at another quarter of double-digit US growth, but ended up with a slight overall decline in Q1 US revenue due to March procedures being down an estimated -18% vs March 2019. 

Among the many topics covered in the comprehensive Q120 Spine Market Recap* are:

Topics: Orthopedics
Continue Reading
7 min read

The Week in Regenerative Medicine: Virtual Meetings, Studies and New Products

By Thomas Wallick on 6/16/20 6:30 AM

As states begin to loosen restrictions and we try and put COVID-19 in the rear view mirror, in the words of Bill Gates, "it's going to be a while before we can get back to normal" and companies are going to have to find creative ways to stay connected and engaged while moving forward and getting work done.

The following is a small sampling of Regenerative Medicine segment updates from the past week that were compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present news, analysis, studies, trial results, patents and financial data that are most relevant to our subscribers.

TOBI 2020 Virtual Conference

For 2020, the TOBI Conference was held virtually due to COVID-19; still, attendance was fairly high. During one of the Virtual Lounge Q&A discussions, it appears that there is an emerging trend w/ some practitioners doing PRP inj then HA inj, not the other way around for knee.

Bone Therapeutics
BOTHE informed that in EU several clinical sites for JTA-004 Phase III trial have resumed recruitment as COVID-19 lockdown measures are lifted; 34 pts have been treated since the initiation of the trial mid-May 2020. Reporting of the topline results is currently planned for H221.

Detachable Hybrid Microneedle Depot for Localized Delivery of MSCs

This study presents a detachable hybrid microneedle depot (d‐HMND) for cell delivery The system deploys an array of "microneedles" w/ MSCs embedded in a gel-like matl, which prolongs cell viability & functionality, penetrating into a target tissue w/ high spatial precision. ADFM

PRP Formulations and Uses

US Patent Application “PLATELET RICH PLASMA FORMULATIONS AND USE THEREOF” was published, relating to compositions for PRP depleted in neutrophils to treat damaged connective tissue &/or slow/stop cardiac apoptosis after a heart attack, along w/ reperfusion therapy. 20200179455

Continue Reading
5 min read

Covid-19 Causes Extremities Market to Pull Up Short in Q120

By Lisa Mahan on 6/15/20 9:30 AM

The Extremities Market was on track to post a strong Q120 finish but due to COVID-19 the market pulled up short

The Extremities Market was in position to post a strong finish in Q120, driven by gains in the US. But the market pulled up short due to the postponement of elective and non-urgent procedures resulting in the US Extremities Market, declining -1.9%, according to SmartTRAK Financial Dashboard.

Among the many topics covered in the comprehensive Q120 Extremities Market Recap* are:

Topics: Orthopedics
Continue Reading
4 min read

Meet Joe Mish - Director of Sales

By Thomas Wallick on 6/11/20 4:19 PM


We are pleased to announce that Joe Mish has joined the team at SmartTRAK as Director of Sales. Joe has 10+ years experience in medical device sales, with concentration on Joint Replacement and Spine & Robotic Technologies. Prior to joining SmartTRAK, Joe sold and implemented analytic software to manage value-based care and bundled payment, working with Stryker, LDR/ZimmerBiomet and Stryker Performance Solutions.

Meet Joe Mish:

What is your role with SmartTRAK? I will be joining the commercial team as Director of Sales.

What do you like about SmartTRAK? I’ll give you two perspectives here. First, with regards to the technology, I love the value proposition to our current and prospective customers. With the world being so volatile and business being severely disrupted (especially for surgery and device companies) being able to offer a solution to reduce risk, improve profitability and productivity makes this a fantastic time to partner with organization’s and build strong, long-lasting relationships. This was truly a deciding factor in making a career/company change. Second, with regards to the company, I love the people. Coming from multiple large Fortune 500 companies with very specific cultures, individuals and team comradery is often and easily overlooked. I have been so impressed with the professionalism, transparency and family vibe from every person I have engaged with and I have only been on board for a week! This feels like a very special group of incredibly talented people and I am honored to be a part of it.

Continue Reading
6 min read

The Week in Wound Care: New Studies, Products and COVID-19 Impacts

By Thomas Wallick on 6/8/20 7:37 PM

As the world begins to reopen from COVID-19, the wound care industry is making progress on new medical devices and studies. The following is a small sampling of Wound Care segment updates from the past week that were compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers.
 
Alliance of Wound Care Stakeholders - CMS COVID-19 
  • The Alliance of Wound Care Stakeholders requested that CMS allow HOPDs and MDs to bill for furnishing dNPWT during the COVID-19 pandemic when providing wound assessment and instruction to patients in their home on the application of dNPWT via telehealth.
  • The Alliance of Wound Care Stakeholders submitted comments to CMS COVID-19 Public Health Emergency Interim Final Rule. The Alliance supported the Agency’s implementation of many policies while also pursuing clarification on several specific provisions.
Pressure Injury in China

A study of 1,806 nurses from 10 hospitals in China on nurses' knowledge, attitudes and behaviors for promoting PI-prevention found 41.7% had insufficient PI-prevention knowledge, 46.6% had negative PI-prevention attitudes, and 21.8% had poor PI-prevention behavior. J Clin Nurs

Improved Textured Breast Implants

Establishment Labs’ US Patent Application “TEXTURED SURFACES FOR BREAST IMPLANTS” was published, describing irregularly-textured breast implants with significantly improved cellular response over current textured implants. 20200170771

Continue Reading
6 min read

Q120 US Joint Fluid Replacement Market: Riding Out the COVID-19 Storm

By Freddy Buntoum on 6/8/20 5:35 PM

Coming through Q120 bruised and expecting much harder punches before the calm, companies ride the COVID-19 storm

According to SmartTRAK Financial Dashboard, Q120 revenue for the US Joint Fluid Replacement market was down -2.8%, which is within the range predicted by market leaders and physicians in SmartTRAK’s Impact of COVID-19 on the US Joint Fluid Replacement and Regenerative Medicine Injectable Markets for Knee OA*. Albeit revenue is down for Q120, the stay-at-home orders across US states triggered by the rapid spread of COVID-19 were not implemented until mid-March, which helped to mitigate what could have been much bigger losses. 

Among the many topics covered in the comprehensive Q120 US Joint Fluid Replacement Market Recap* are:

Continue Reading
4 min read

Q120 Total Joints Market Recap: COVID-19 Hits the Brakes on Growth

By Lisa Mahan on 6/4/20 12:26 PM

COVID-19 pandemic hit the brakes mid-March resulting in a quick growth slow-down

Q120 was looking like a strong first quarter following Q420’s 4.5% YoY growth, the highest rate seen in the US Total Joints Market for several years. But, the COVID-19 pandemic and the institution of stay-at-home orders in most US states put the brakes on elective procedures in March, resulting in -4.8%, according to SmartTRAK Financial Dashboard. The postponement of procedures and the resulting downturn in revenue late in Q120 also resulted in orthopedic companies withdrawing guidance due to uncertainty about the timing of recovery.

Among the many topics covered in the comprehensive Q120 US Total Joints Market Recap* are:

Topics: Orthopedics
Continue Reading
4 min read

This Week in Ortho: Projecting the Market's COVID-19 Recovery

By Thomas Wallick on 6/1/20 6:53 PM

As access to healthcare continues to open up, the orthopedic industry is taking significant precautions to insure the health, safety and piece of mind of patients and caregivers and balance that with its attempt to ramp up services and procedures. The following is a small sampling of the orthopedic updates compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers:

Updated Survey Data Points to Recovery by Q420

WFS’ new survey of 623 US-based physicians (15 specialties) shows that in orthopedic, the % of procedures expected to be postponed due to COVID-19 for both TKR and THR declined from 94% (Wave 1) to 85% (Wave 2). WFS MedTec: Updated Survey Data Points to Recovery by Q420

Impact of COVID-19 on the Spine Market

Of deferred spinal fusion procedures, surveyed surgeons now expect 74% of cases to be performed at a later date w/ 26% cancelling. Reasons for cancellation include pt seeking treatment w/ a different surgeon (26%) and underlying condition improving (23%). WFS MedTech Survey

Robotic Procedures Affected by COVID-19

Based on its survey of 623 US-based physicians across 15 specialties between April 27 and May 8, WFS notes that in general the % of robotic & laparoscopic procedures across all specialties declined compared to pre-COVID 19 levels, while the % of open procedures increased.

Continue Reading
12 min read

Unique Biomaterials Opportunity: An Interview with Michael Ziebell of trū Shrimp

By Susan Paquette on 5/27/20 12:44 PM

.SmartTRAK discusses a new biomaterials opportunity for medical devices with Michael Ziebell, President and CEO of trū Shrimp.

Shrimp is the most popular seafood in the US with an annual consumption of 1.6 billion pounds and 90% sourced outside the US. trū Shimp has developed a unique aquaculture for raising shrimp that allows production to occur anywhere in the US, even in Minnesota. Michael Ziebell explains the unique features of the process and its ability to produce a novel biomaterial that may be tailored to meet the needs of the medical device industry.

A transcript of SmartTRAK’s interview with Michael Ziebell is below. To listen to the audio interview, click on the video (10:39 minutes). The full transcript, with a link to download a PDF, is provided below.

Topics: Wound Care
Continue Reading
7 min read

COVID-19: Vaccines, Testing and the Future for MedTech

By Thomas Wallick on 5/26/20 8:00 AM

With social distancing and travel restrictions easing worldwide, and WHO warning of a possible second peak of the pandemic, the work continues on potential vaccines to prevent COVID-19 and treatments for those already affected by the virus. The following is a small sampling of the COVID-19 updates compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers:

Remdesivir Shortens Recovery Times in COVID-19 

Preliminary results of a double-blind, randomized, placebo-controlled trial of IV remdesivier in adults hospitalized w/ COVID-19 and lower respiratory tract infection showed remdesivir was superior to placebo in shortening recovery times (11 days vs 15 days; p=0.001). NEJM

Orthopedic Surgery During COVID-19

This JBJS article discusses medically necessary orthopaedic surgery during the COVID-19 pandemic and recommends safe surgical practices and a classification to guide tx. JBJS

US Plans Massive COVID-19 Testing Effort to Deliver Vaccine by YE20

The US plans a massive testing effort involving more than 100K volunteers and ~6 of the most promising vaccine candidates in an effort to deliver a safe and effective one by YE20, compressing what is typically 10 yrs of vaccine development/testing into a matter of months. Reuters

COVID-19: Vaccine Shows Promise in Early Trial

Moderna reports preliminary data suggests its COVID-19 vaccine is safe and appears to be eliciting an immune response in test subjects. The FDA has given the Company approval to begin a Phase II study w/ ~600 volunteers. A Phase III study may begin by July. NPR

Continue Reading
5 min read

Biomedical Solutions: An Interview with DSM Biomedical's John Witkowski

By Kim French on 5/20/20 10:00 AM

SmartTRAK discusses the latest advancements in biomedical solutions with DSM President John Witkowski

DSM, a global leader in biomedical solutions for more than 30 years, helps improve the health of 3.5 million patients annually. While biomaterials have been around for decades, DSM Biomedical is advancing biomaterial science, providing the latest synthetic biomaterials and stem cell-based technologies that are used in various applications, including spine, general orthopedics, sports medicine, general surgery and wound.

To learn more about the latest advancements in DSM Biomedical biomaterials and technologies and what’s next for the business, click on the following video to listen to SmartTRAK’s interview with John Witkowski, President of DSM Biomedical. A transcript of the interview can also be downloaded below. 

Continue Reading
1 min read

SmartTRAK Introduces Computer Assisted Surgery Financial Dashboard

By Lindsey Wolejko on 5/18/20 4:15 PM

We are excited to announce the launch of Computer Assisted Surgery's Financial Dashboard. SmartTRAK's financial analysis is highly regarded and frequently cited by many in the industry for its accuracy and comprehensiveness. As the Computer Assisted Surgery industry continues to evolve, it's more important than ever for industry players to stay on top of the market financials.  

Financial Dashboard makes it easy to:
  • Size a market
  • Gauge market share
  • Compare year-over-year growth
  • Spot financial trends

Topics: Orthopedics
Continue Reading
7 min read

COVID-19: Restrictions Ease as Vaccine Development Ramps Up

By Thomas Wallick on 5/18/20 3:29 PM

As restrictions begin to ease around the world, the Life Sciences industry prepares to deal with the impending ramifications. While progress is being made on vaccines and treatments as new surgery guidelines are developed, the potential long term consequences of the pandemic must be addressed. The following is a small sampling of the COVID-19 updates compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers:

COVID-19: WFS Call on Reopening America

During a Wells Fargo call, Dr. Ashish Jah, Dir of Harvard Global Health Institute, projected the US economy will ramp up to 80% open by fall w/ an increase of elective procedures in the summer to 100% or higher. He doesn’t anticipate a fall return of COVID halting procedures.

Impact of COVID-19 on Spine Procedures

Based on conversations with healthcare and industry professionals, SmartTRAK expects deferred spine procedures to reschedule more quickly than many other procedures due to the non-elective nature of spine cases – particularly those w/ neurological deficit or progressive pain.

Pfizer's COVID-19 Vaccine in Human Trials

Pfizer working alongside German drugmaker BioNTech injected its potential COVID-19 vaccine in first human participants last week and hopes to test up to 360 people in its clinical trial. If the vaccine is found safe and efficacious it could be available starting in Oct. CNBC.com

Continue Reading
7 min read

Trends in Spinal Navigation: An Interview with TrackX CEO Dr. Rob Isaacs

By Julianne Burns on 5/14/20 11:36 AM

Companies like startup TrackX Technology are taking navigation technology to the next level to provide real-time instrument tracking while minimizing radiation exposure during minimally invasive spine procedures.

Enabling technologies, including robotics and navigation systems in spine surgery, are here to stay and were on display at the Spine Summit 2020 meeting held in Las Vegas, Nevada from March 5-8. While navigation has been around for decades, companies like startup TrackX Technology are taking the technology to the next level to provide real-time instrument tracking while minimizing radiation exposure during minimally invasive spine procedures.

Topics: Spine
Continue Reading
3 min read

Weathering the COVID-19 Storm in Orthobiologics: An Interview with Steven Sampson, DO

By Freddy Buntoum on 5/11/20 9:00 PM

The COVID-19 pandemic is having a significant effect on physician practices in Orthopedics and Sports Medicine, including the number of elective procedures being postponed, when normal operations might resume, the adoption of telemedicine, delivery of physician education and interactions with industry. To find out more, SmartTRAK Analyst Freddy Buntoum interviewed Steven Sampson, DO, founder of The Orthobiologic Institute (TOBI) and an internationally-recognized expert in the field of non-surgical orthopedics and the science of sports medicine. To hear Dr. Sampson’s take on how things might evolve throughout the rest of 2020, and how his practice and organization are supporting patients and other stakeholders, click on the following video to listen to the interview recorded via Uberconference (25:20 minutes). A transcript of the interview can be downloaded below.

Continue Reading
6 min read

COVID-19 Updates: MedTech Fights Back

By Thomas Wallick on 5/11/20 8:57 PM

While some countries are slowly emerging from their lockdowns, the MedTech industry continues to face unprecedented challenges as it adapts to the changing landscape. SmartTRAK's analysts are constantly monitoring the effect COVID-19 is having on the Life Sciences industry, sifting through the noise to present the most relevant news to its subscribers. Our analysts continue to publish real-time updates throughout the day, detailing what you need to know about the impact the international healthcare crisis is having on the industry at large.

Following is a selection of the COVID-19 updates from the past week as compiled by the analysts at SmartTRAK:

COVID-19: Advamed Issues New Code of Ethics Guidance

Advamed announced the availability of its new “Code of Ethics Compliance Guidance Related to the COVID-19 Response” to help its members and other MedTech companies develop and implement processes supporting rapid decision making and mitigate any related compliance risks.

MedTech Europe 

MedTech Europe, the European trade association representing the medical technology industries, issued a statement around COVID-19 calling attention to the supply situation of medical devices. They also highlighted that some contracts need to be revised and analyzed.

COVID-19: FDA Removes Respirators Manufactured in China

In a letter to healthcare providers, the FDA announced it removed a number of EAU disposable filtering facepiece respirators manufactured in China. The products pulled failed to demonstrate a minimum particulate filtration efficiency of 95% in testing conducted at NIOSH. fda.gov

Continue Reading
6 min read

COVID-19: The MedDevice Industry Navigates Uncharted Waters

By Thomas Wallick on 5/4/20 6:12 PM

The world-wide medical community continues to search for ways to stem the spread of the COVID-19 virus and deal with its impact. Progress is being made on vaccines and treatments as new surgery guidelines are developed. The following is a small sampling of the COVID-19 updates compiled, reviewed and posted in real-time by our SmartTRAK analysts, who are constantly monitoring the situation and sifting through the noise to present the most relevant news to our subscribers:

AAHKS Survey Shows COVID-19's Effect on MedDevice Industry
Results from a survey of AAHKS Industry Partners indicates an increasing shift to web-based prof ed through 2021, and for H220, a significant emphasis on outpt care, COVID-19 safety measures, and the need for increased availability of instruments and implants. J of Arthroplasty

More Signs COVID-19 Vaccines Coming

There are add’l signs a COVID-19 vaccine could be available in late 2020/early 2021. JNJ and Catalent are preparing for 24/7 manufacturing of JNJ’s investigational vaccine candidate. Also, Pfizer believes it may have a vaccine for emergency use by late Q3/early Q4. Seeking Alpha

FDA Allows Emergency Use of Potential COVID-19 Treatment

The FDA issued emergency use authorization for Remdesivir, an investigation ant-viral drug, for the treatment of suspected or lab-confirmed COVID-19 in adults and children hospitalized for severe conditions. FDA.gov

Continue Reading
3 min read

Q419/FY19 Soft Tissue Fixation Market Recap: Overall Positive Growth

By Freddy Buntoum on 4/29/20 9:21 AM

For the fourth quarter of 2019, WW Soft Tissue Fixation Market revenue was up +3.7% YoY. Aggregate growth for the quarter especially benefited from healthy and continued revenue gains in the Hip Labral repair segment, which was up +8.9% YoY. And, to a smaller extent, the Meniscal repair and the Shoulder repair segments also contributing to the overall WW market growth in Q419 with YoY increases of 4.4% and 4.1%, respectively, based on SmartTRAK Financial Dashboard. Similar to other orthopedic markets, such as the Joint replacement market, Soft Tissue Fixation is typically seasonal with lower sales during Q3 and recovery in Q4 driven by a year-end increase in the number of elective procedures and stronger product push as competitors race to finish the year at or above their respective budget projections.

Continue Reading
5 min read

COVID-19 Updates: The State of MedTech as Reopening Begins

By Thomas Wallick on 4/27/20 3:35 PM

The Covid-19 crisis continues to impact the world-wide medical community. As some parts of the world take steps toward reopening, a more complete picture is forming of the effects on the global Life Sciences industry. SmartTRAK's analysts are constantly monitoring data and sifting through the noise to present the most relevant news to its subscribers in real-time updates throughout the day.

Following is a small sampling of the hundreds of COVID-19 updates from the past week that were compiled, reviewed and posted by our analysts on SmartTRAK:

Mesoblast MSC Product Initially Proves Successful in COVID-19 Related ARDS 

Mesoblast announced 83% survival in ventilator-dependent COVID-19 pts w/ moderate/severe acute respiratory distress syndrome (ARDS) treated w/ two IV infusions of remestemcel-L (allogenic MSCs) w/in the first five days.

Impact of COVID-19 on CAS in the US
SmartTRAK took a preliminary look at the impact of the COVID-19 pandemic on procedure volumes & capital equipment placement of orthopedic and spine enabling technologies, with projected recovery into 2021. Impact of COVID-19 on US Orthopedic and Spine Computer-Assisted Surgery

Impact of COVID-19 on Advanced Wound Care
SmartTRAK assessed the impact of COVID-19 on the NPWT Market. Single-use volumes are expected to drop during the first three quarters of 2020 due primarily to the drop in elective surgical procedures but will rebound in Q420. Impact of COVID-19 on US Advanced Wound Care

Continue Reading
4 min read

Q419/FY19 Infection Prevention Recap: VA Adjunct Products Post Gains

By Susan Paquette on 4/24/20 12:39 PM

FY19 showed solid gains in all segments, up +4.1% YoY, as antimicrobial devices take the lead

The prevention of Hospital-Acquired Infections (HAIs) continues to drive measures and practices to reduce Central Line-Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. Numerous programs and educational tools are being developed to provide measures and strategies that assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

According to BioMedGPS' SmartTRAK Financial Dashboard, the Q419 US VA Adjunct Products market saw a solid increase of +3.7% for the four segments: Dressings, Antimicrobial Devices, Antimicrobial IV Skin Preps and Mechanical Securement Devices.

Among the many topics including news, financial data, charts and company revenues, covered in the comprehensive Q419/FY19 Infection Prevention: Vascular Access Adjunct Products Market Recap*, are:

Topics: Wound Care
Continue Reading
4 min read

Q419/FY19 Market Recap: Innovation Amid Weakness in SCS

By Anne Staylor on 4/23/20 9:30 AM

Although the Spinal Cord Stimulation (SCS) Market was down YoY in Q419 and FY19, new data and devices are on deck for 2020

Continue Reading
5 min read

COVID-19: The Life Sciences Industry Rises to the Challenge

By Thomas Wallick on 4/20/20 3:29 PM

As the Covid-19 epidemic continues, the medical community world-wide struggles to cope with its impact. SmartTRAK's analysts are constantly monitoring the effect COVID-19 is having on the Life Sciences industry, sifting through the noise to present the most relevant news to its subscribers. Our analysts continue to publish real-time updates throughout the day, detailing what you need to know about the impact the international healthcare crisis is having on the industry at large.

Following is a selection of the COVID-19 updates from the past week as compiled by the analysts at SmartTRAK:

New CMS Guidelines for Providing Non-COVID-19 Care
CMS issued guidance on providing a gradual process for restarting non-COVID-19 care in areas w/ low incidence of the disease including coordination w/ local and state public health officials and readiness assessment in terms of staff, supply and testing capabilities. CMS.gov

AHA & Others Develop Joint Guidelines for Resuming Elective Procedures
AHA, ACS, ASA and AORN have developed joint guidelines to help providers determine their readiness to resume elective procedures including a sustained reduction in COVID-19 cases in their geographic area for at least 14 days and having the appropriate resources. AHA.org

Switzerland Easing Restrictions While Others Extend Theirs
Switzerland announced a 3-step plan for easing restrictions due to COVID-19 including allowing hospitals to perform elective procedures. The UK, however, extended its lockdown for 3 more weeks similar to extensions in Italy, Spain, and France. CIDRAP

Continue Reading
3 min read

Q419/FY19 AWC Market Recap: Solid Growth and Acquisitions

By Susan Paquette on 4/20/20 9:00 AM

A year of solid growth and acquisitions for the WW AWC market, as 3M moves into the leading position.

For FY19, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +4.7% YoY.

3M captured the number one position in the AWC space after completing the acquisition of Acelity and its KCI subsidiaries on October 11, 2019. According to SmartTRAK Financial Dashboard, in FY19, combined 3M and Acelity seized 22.7% of the market and generated +6.2% YoY growth. Revenue for Q419 was up +6.9% YoY, driven by ongoing strong performance in single-use negative pressure wound therapy and solid growth in Advanced Wound Dressings. 

Among the many topics, including news, financial data, charts and company revenues, covered in the comprehensive Q419/FY19 Advanced Wound Care Market Recap*,  are:

Topics: Wound Care
Continue Reading
9 min read

Swim with the Sharks: A Deep Dive in the Biologic Association Think Tank

By Freddy Buntoum on 4/17/20 2:23 PM

The Biologic Association kicked off its very 1st Summit (Feb 5-7, 2020 in Carlsbad, CA) with what turned out to be a big crowd-pleaser. Initially set up as a “by invitation only” attendance, the Summit’s opening program, “Biologic Association Think Tank” raised such a high level of interest that everyone in attendance was ultimately let into the session.

The format for the Think Tank was quite similar to the hugely popular television show “Shark Tank.” Only in this session, the “school of fish” (contestants/presenters) included a lineup of industry and/or academic researchers in the field of Orthobiologics who gave presentations on their respective lead product candidates.

Continue Reading
3 min read

Q419/FY19 CAS Spine Market Recap: Robotics Drives Implant Sales

By Elise Wolf on 4/15/20 2:29 PM

Robotics and other enabling technologies continued to drive implant sales for existing competitors in Q419, with several new product introductions and expanded applications expected in 2020 and beyond.

Topics: Orthopedics
Continue Reading
6 min read

COVID-19: MedTech Navigates the Pandemic

By Thomas Wallick on 4/13/20 1:31 PM

As Covid-19 tightens its grip on the global community, the impact on the world economy grows. SmartTRAK's analysts are constantly monitoring the effect COVID-19 is having on the Life Sciences industry, sifting through the noise to present the most relevant news to its subscribers. Our analysts continue to publish real-time updates throughout the day, detailing what you need to know about the impact the international healthcare crisis is having on the industry at large.

Following is a selection of the COVID-19 updates from the past week as compiled by the analysts at SmartTRAK:

COVID-19 Could Travel in Air Up to 13 Feet
New research published by the CDC showed COVID-19 was detected in air up to 4 m (~13 feet) from pts in a study that tested surface and air samples from a hospital w/ COVID-19 pts in Wuhan, China. The virus was detected on floors, computer mice, doorknobs, bed rails & trash cans.

COVID-19: Roadmap for Reopening the US

A report by former FDA commissioner Scott Gottlieb, MD and colleagues at the American Enterprise Institute provides a roadmap for navigating through the COVID-19 pandemic in the US and outlines steps needed to start reopening America for businesses and families. AEI

DSM Launches Site to Support COVID-19 Efforts
With COVID-19 disrupting supply chains and causing shortages, DSM has launched a web page that brings together designs and resources for people looking to help alleviate the supply issues using 3D printing technology.

Continue Reading
8 min read

Stemless Humeral and Inlay Glenoid Implants: An Interview with Dr. Gregory Nicholson

By Lisa Mahan on 4/13/20 9:30 AM

New research shows excellent results for anatomic TSA using a stemless humeral component with an inlay glenoid. Dr. Gregory Nicholson gives the breakdown on the research, indications, market acceptance and limitations. 

In the market for total shoulder arthroplasty (TSA), younger, active patients with degenerative conditions of the glenohumeral joint are a unique and more complicated population for surgeons to treat with TSA. Challenges in treating this cohort include higher functional demands that can lead to implant wear and failure. However, a recent study suggests a new implant design might be a good option these types of patients, potentially filling a treatment gap and expanding the market for TSA.

Continue Reading
3 min read

Q419/FY19 US Hemostats and Sealants Market Recap: Solid Growth

By Doug Devens on 4/10/20 10:18 AM

The US market for Hemostats and Sealants grew +5.8% YoY in Q419, comparable to its +6.2% growth in Q319, with continued strength in fibrin sealants and good growth in absorbable hemostats.

As reported in SmartTRAK Financial Dashboard, the US Hemostats and Sealants market maintained a solid growth rate of +5.8% in Q419 and grew +5.7% YoY. Leading the way in Q419 was Becton Dickinson (BD),  as its relaunch of Progel continued its resurgence. Baxter also posted strong gains.

Among the many topics covered in the comprehensive Q419/FY19 US Hemostats and Sealants Market Recap* are:

Topics: Wound Care
Continue Reading
3 min read

Q419/FY19 Trauma Market Recap: Comps & Pricing Pressure Dampens Growth

By Natasha Weeks on 4/8/20 9:42 AM

Tough comps and pricing pressure dampen growth during Q419

According to BioMedGPS’ SmartTRAK Financial Dashboard, the WW Trauma Market posted +2.8% growth, down from Q3, while the US achieved growth of +3.8%, also down from Q3. Trauma market leader DePuy Synthes (48.6% US Q4 share) reported while sales were down compared to Q319, gains were driven by overall market growth and strong adoption of their Femoral Neck System.

Tough comparisons, both YoY and sequentially, impacted the Q419 Trauma Market. The US pricing environment remains relatively steady as DePuy Synthes noted pricing pressure of -2.0%, in line with their Q2 and Q3 pricing (Q1 was -2.5%). Zimmer Biomet’s SET pricing improved in Q4 at -1.8% vs. Q3’s -2.0%. BioMedGPS believes 2019 pricing trended at -2.0 to -2.5%.

Among the many topics covered in the comprehensive Q419/FY19 Trauma Market Recap* are:

Topics: Orthopedics
Continue Reading
5 min read

COVID-19: MedTech Confronts the Pandemic

By Thomas Wallick on 4/6/20 3:50 PM

Covid-19 continues to spread across the globe, and, like the rest of the world, the MedtTech industry is strategizing the best ways to deal with the pandemic. SmartTRAK's analysts continue to monitor the effect COVID-19 is having on the Life Sciences industry, sifting through the noise to present the most relevant news to its subscribers and report on the impact the global healthcare crisis is having on the industry at large.

Following is a selection of the COVID-19 updates from the past week as compiled by the analysts at SmartTRAK:

OTA COVID-19 Webinar

  • OTA Special Webinar COVID-19: Preparedness in Orthopaedic Trauma OTA Panel Discussion was held 4/2/10. Panel included 9 OTA Trauma surgeons. For a recording of the Webinar, go to: COVID-19: Preparedness in Orthopaedic Trauma OTA Panel Discussion.
  • As a result of COVID-19 and stay at home orders, trauma surgeons are seeing a definite decrease in volumes, with polytrauma being almost negligible in certain cities. Geriatric fractures have decreased but to a lesser extent according to the OTA COVID-19 Webinar discussion.
  • According to the OTA webinar panel discussions, trauma surgeons are taking resource allocation into consideration when assessing fracture care of the clavicle, humeral shaft or fibula and deciding whether to treat conservatively vs. operate in areas with COVID-19 surges.

COVID-19 Risks to Clinical Trials
The impact of COVID-19 has been immense. This article reviews eight significant risks COVID-19 poses to clinical trials and how to mitigate them.

COVID-19: Projections of Peak and Procedure Returns
The Institute for Health Metrics and Evaluation is now projecting lower overall hospital resource needs in the US and predicts the peak will be April 15. Based on this, WFS estimates elective procedures will be depressed through June.

Continue Reading
4 min read

Q419/FY19 Orthobio Market Recap: Decelerating Growth

By Kim French on 4/3/20 9:46 AM

Surprises lead to deceleration of overall Orthobio growth

For Q419, US Orthobio market growth (comprised of Bone, Cartilage, Soft Tissue and Meniscus Replacement implants) was flat at 0.3%. FY19 grew 4.2% over 2018. Both Q4 and FY19 did see shifts within the market. The double-digit growth of Cartilage and Wright’s AUGMENT was offset by lower than expected sales in InfuseCartiva SCI and soft tissue augmentation. For 2019, Medtronic remained the overall US market leader, followed by DePuy Synthes and Stryker.

Among the many topics covered in the comprehensive Q419/FY19 OrthoBio Market Recap* are:

Continue Reading
4 min read

COVID-19: Increasing Impact on the Life Sciences Industry

By Thomas Wallick on 3/30/20 1:11 PM

As the COVID-19 pandemic progresses, the MedTech industry is continuing to see a multitude of changes and disruptions worldwide. SmartTRAK's analysts continue to monitor the effect COVID-19 is having on the Life Sciences industry, sifting through the noise to present the most relevant news to its subscribers and report on the impact the global healthcare crisis is having on the industry at large.

Following is a selection of the COVID-19 updates from the past week as compiled by SmartTRAK:

Surgeon Survey: COVID-19 Impact

  • A survey of 50 orthopedic surgeons reported ~40% are still seeing both new and existing pts, while a third is only seeing pts for emergency or urgent issues. Telemedicine adoption has accelerated w/ 32% of survey takers noting some recent use. Canaccord Genuity Industry Report
  • According to a 50-surgeon survey, postponements of orthopedic procedures have led to a sharp decline in pt volumes, w/ respondents indicating a 58% avg decline in March and an anticipated 77% avg decline in April. Canaccord Genuity Industry Report
  • According to a 50-surgeon survey, 60% indicated that their organizations had already made formal decisions to defer or postpone orthopedic procedures, w/ ~33% indicating that over 90% of their entire practice was deferrable. Canaccord Genuity Industry Report

COVID-19: NV Procedure Impact
  • SmartTRAK physician checks suggest elective procedure volumes for aneurysm cases will pick up in H219, assuming social isolation and other non- pharmaceutical interventions effectively reduce the spread of COVID-19 and healthcare demand.
  • SmartTRAK is hearing from neurointerventionalists that COVID-19 is affecting elective procedure volumes for aneurysm cases, but those patients are being rescheduled—not canceled. Mechanical thrombectomy procedures have not been impacted to date.
Continue Reading
4 min read

Q419/FY19 US Surgical Matrices Market Recap: Robust Growth

By Doug Devens on 3/27/20 9:49 AM

The US Surgical Matrices Market showed robust growth in Q419, improving on Q319. Breast matrices rebounded from its Q319 malaise, while hernia matrices grew YoY.

In Q419, the US Surgical Matrices Market grew +8.5% YoY, and was up +4.2% for FY19 according to BioMedGPS’ SmartTRAK Financial Dashboard. Allergan broke out of its  Alloderm supply constraints, and Becton Dickinson (BD) also did quite well.
  • Q419 Breast Matrices market found its groove again, up YoY. For FY19 Breast Matrices grew well, despite several weak quarters.
  • Q419 US Hernia Matrices market increased its growth, with the highest growth rate in biosynthetics and with both xenografts and allografts showing surprising strength. For the year, Hernia Matrices edged up.
  • Allergan beat its supply constraints and maintained its leadership of the Breast Matrices market, as Alloderm returned to the market in force. For the full year, Allergan slid due to those Alloderm supply problems.
  • BD maintained its No. 1 position in the Q419 Hernia Matrices market.

Among the many topics covered in the comprehensive Q419/FY19 US Surgical Matrices Market Recap* are:

Topics: Wound Care
Continue Reading
3 min read

Q419/FY19 Extremities Market Recap: Healthy Competition

By Lisa Mahan on 3/26/20 9:30 AM

Healthy competition ignited by new product intros propels extremities arthroplasty while fixation runs into tough comps along with a lack of new product drivers

Topics: Orthopedics
Continue Reading
6 min read

A Critical Crossroads for COVID-19: An Interview with Krishnan Chakravarthy

By Anne Staylor on 3/23/20 6:06 PM

Krishnan Chakravarthy, MD, PhD discusses the state of the pandemic and its impact on pain medicine in an interview with SmartTRAK

Krishnan Chakravarthy, MD, PhD discusses the COVID-19 pandemic, current and evolving methods for containing and treating the virus, how it's changing the practice of pain medicine and its impact on industry in an interview with SmartTRAK. Dr. Chakravarthy is Chairman of the COVID-19 Task Force for the American Society of Pain and Neuroscience (ASPN), a virologist, pain management specialist and assistant professor of anesthesiology at the University of California, San Diego (UCSD). 

To find out more, including lessons learned from the 1918 Spanish flu pandemic, click on the following video to listen to the interview conducted by Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, recorded live via Uberconference (47:29 minutes).  Specific interview topics by time code are also outlined below, as is a link to download the transcript.

Continue Reading
6 min read

SmartTRAK COVID-19 Updates: Early Effects on the MedTech Industry

By Thomas Wallick on 3/19/20 2:00 PM

As the COVID-19 pandemic continues to develop rapidly, the MedTech industry is already seeing many changes and disruptions. SmartTRAK has collected updates and news from the last few days concerning the spread of COVID-19 and how it is affecting the Life Sciences Industry.

COVID-19 AWCS

  • Alliance of Wound Care Stakeholders (AWCS) held an emergency call to discuss hospital wound care clinics being considered non-essential and being asked to close due to COVID-19. Participants included wound clinics, providers and manufactures.
  • Medical Directors from Healogics and Restorix, and other wound clinics requested the AWCS publish a one page fact sheet asap stating the importance of wound clinics staying open for challenging pts, as w/o care, the probability of needing emergency care increases significantly.

ACS Issues Decision-Making Guidance on Elective Procedures
With calls to curtail elective surgery, the ACS published guidance on the mgmt of non-emergent operations and suggests surgeons use SLU’s Elective Surgery Acuity Scale to help decide whether procedures should be postponed, performed at an ASC or not postponed.

Tracking COVID-19 via Smart Phones
The US Government is talking w/ tech companies (Facebook, Google, etc) and health experts re how they can use data gleaned from Americans’ phones to map the spread of COVID-19 to predict the next hotspot or decide where to allocate resources. Seattle Times

Continue Reading
4 min read

Q419/FY19 Spine Market Recap: Strong Growth

By Julianne Burns on 3/19/20 10:00 AM

Improvements in procedure volumes drove strong growth across the spine hardware market.

Improvements in procedure volumes drove positive growth across the spine hardware market, with the WW spine hardware market up for Q419 and FY2019, respectively, according to the SmartTRAK Financial Dashboard. Similarly, Cantor Fitzgerald analysts estimate 2019 global spine market (inclusive of biologics) growth at +2.2%, the highest growth the market has seen in 5 years, with +2.1% US growth and +2.2% growth OUS.

Among the many topics covered in the comprehensive  Q419 Spine Market Recap*  are:
Topics: Orthopedics
Continue Reading
4 min read

Q419/FY19 Total Joints Recap: US Market Strengthens

By Lisa Mahan on 3/19/20 10:00 AM

Product Mix Shift and Improved Pricing Strengthens US Total Joints Market

In the US, revenue in the Total Joints market for Q419 achieved much stronger growth compared to Q418, according to SmartTRAK Financial Dashboard. Both Hip and Knee Replacement market segments saw growth acceleration. Keep in mind that this growth does not include revenue generated by the sale of robotic systems and associated disposables. The Total Joints market is typically seasonal with a dip in sales during Q3 with recovery in Q4. However, Q419’s uptick seemed particularly strong benefiting from mix shift in products, including the increasing popularity of cementless knees and dual mobility hips.

Among the many topics covered in the comprehensive Q419 US Total Joints Market Recap* are:

Topics: Orthopedics
Continue Reading
1 min read

Q419/FY19 US Joint Fluid Market Recap: Stronger Demand for Single Injection

By Freddy Buntoum on 3/16/20 2:14 PM

Overall, 2019 was a good recovery year for the US Joint Fluid market with Single-injection treatment options at the helm

For Q419, revenue in the US Joint Fluid market was up, recovering fairly well from a year ago according to SmartTRAK Financial Dashboard. Aggregate growth for the quarter was attributable to a double-digit revenue growth in single injection. Stronger demand and heavy product push in that segment, especially at year-end, was offset to a certain extent by revenue declines in 3- and 5-injections. 

Among the many topics covered in the comprehensive Q419 US Joint Fluid Market Recap* are:

Continue Reading
5 min read

Medtronic Ups its Game with Percept DBS and BrainSense Technology

By Anne Staylor on 3/13/20 9:30 AM

Mike Daly, VP and GM of Medtronic’s Brain Modulation, discusses the Company’s new Percept DBS System with BrainSense Technology in an interview with SmartTRAK

Although Medtronic has lost share in deep brain stimulation (DBS) over the last several years, the Company upped its game recently with the EU launch of its new Percept PC Neurostimulator with BrainSense technology, which received CE Mark in January 2020. Percept is a primary cell DBS device that can send and record brain signals while delivering therapy to patients for the treatment of symptoms associated with Parkinson’s disease, essential tremor, primary dystonic, epilepsy and obsessive-compulsive disorder.  Although Percept is currently available in the EU for open-loop sensing, the device is closed-loop capable, and Medtronic plans to conduct additional research in closed-loop DBS in hopes of eventually gaining regulatory approval for an Adaptive DBS system. 

To find out more about Percept DBS, BrainSense technology and what’s next for Medtronic’s Brain Modulation Business, click on the following video to listen to SmartTRAK’s interview with Mike Daly, Vice President and General Manager of the Brain Modulation Business within Medtronic. A transcript of the interview is also provided below.

Continue Reading
9 min read

Recent Studies Announced in Advanced Wound Care

By Lindsey Wolejko on 3/6/20 1:03 PM

In this week's round-up of recent Medtech studies, SmartTRAK takes a deeper look at the Advanced Wound Care market. Our analysts have picked out some of the latest developments on Smith & Nephew and Avita Medical's products, as well as Pressure Ulcer and NPWT studies.
 

A 304-pt trial will measure the efficacy of PICO in the prevention of SSI from cardiac surgery under extracorporeal circulation vs Aquacel Surgical. The primary outcome is incidence of infection of the sternal wound. Est study completion is Jul 13, 2021. clinicaltrials.gov

Find out how to receive SmartTRAK Daily Updates
Continue Reading
6 min read

Wound Care Payer Coverage: An Interview with Marcia Nusgart

By Susan Paquette on 3/5/20 9:00 AM

Marcia Nusgart, Executive Director, Alliance of Wound Care Stakeholders, discusses the upcoming Wound Care Evidence Summit and improving payer coverage in an interview with SmartTRAK.

In the market for wound care products, the success of any product is highly dependent on whether or not manufacturers are able to obtain a positive coverage determination from public and commercial payers. In the last several years, obtaining product reimbursement has been more challenging as payers are restricting coverage for a growing number of wound care products due to a lack of clarity surrounding clinical evidence.

So, what are payers looking for? What and how much clinical evidence do payers need to cover wound care products and procedures? How can manufacturers prepare scientific evidence to meet payer needs, improve coverage and achieve more uniform policies for treating wounds in all healthcare settings? To answer these questions and more, the Alliance of Wound Care Stakeholders is convening payers, regulators, researchers, manufacturers and wound care providers at its upcoming Wound Care Evidence Summit to be held April 1-2, 2020 in Washington, DC.

To find out about the Summit, improving payer coverage and opportunities for industry, SmartTRAK’s Susan Paquette interviewed Marcia Nusgart, Executive Director of the Alliance of Wound Care Stakeholders.

Topics: Wound Care
Continue Reading
14 min read

Shifting Spine Procedures to an ASC: An Interview with Richard A. Kube II, MD

By Julianne Burns on 3/4/20 10:12 AM

Shifting spine procedures to an ASC setting and participating in a free market healthcare environment.

Richard A. Kube II, MD discusses the advantages and challenges of moving spine procedures to an Ambulatory Surgery Center (ASC) setting in an interview with SmartTRAK. Spine surgeon Dr. Kube founded the  Prairie Surgicare Spine Surgical Facility in Peoria, Illinois as well as the Illinois chapter of  Free Market Medical Association. He shares with us why many are choosing an ASC setting as well as the importance of transparency in healthcare. To find out more, click on the following video. A transcript of the interview is also provided below.
Topics: Orthopedics
Continue Reading
3 min read

SmartTRAK Seeking an Enterprise Sales Executive

By Sharon O'Reilly on 3/2/20 4:45 PM

Location: Northeast US near the Boston Area

Full-time Position

Position:

Are you a proven hunter with a successful track record in medical device or healthcare enterprise sales? Are you looking for flexibility beyond your four office walls? Would you thrive in an entrepreneurial environment? If so, we’d like to talk to you. We’re BioMedGPS the creators of SmartTRAK, the leading strategic advisory and healthcare analytics provider in the life sciences industry. Our team is expanding and seeking a Enterprise Sales Executive who can grow with us. The Enterprise Sales Executive will be responsible for selling SmartTRAK’s suite of business intelligence solutions to C- suite and other senior level executives in major medical device companies, as well as building long term strategic programs and relationships at all levels of the enterprise.

About SmartTRAK
SmartTRAK is the first real-time business intelligence portal used by major orthopedic, wound, regenerative medicine and neuro therapies companies. We are driven by data but fueled by insights. Curated by industry experts, our up-to-date data, analytics and competitive intelligence help medical device executives make more informed strategic business decisions.

Learn More and Apply

Continue Reading
4 min read

SmartTRAK Participates in 1st Biologics Alliance Think Tank

By Lindsey Wolejko on 3/2/20 1:53 PM

The Biologics Alliance opened their 1st Summit meeting February 5th in Carlsbad CA with a "Think Tank" session of companies developing new products for the treatment of cartilage-related problems and knee OA. The companies appeared before a panel of judges similar to those on Shark Tank, only these judges had a special expertise in orthopedics/OrthoBiologics. BioMedGPS' CEO Sharon O'Reilly and SmartTRAK Senior Analyst, Kim French were among the panel of judges comprised of industry representatives and analysts/press. Samumed was the first place winner for Lorecivivint (SM04690), Bioventus was 2nd place for PTP-001 and Organogenesis in 3rd w/ ReNu.

Continue Reading
7 min read

SmartTRAK Highlights Recent Studies in OrthoBio

By Lindsey Wolejko on 2/27/20 9:30 AM

Here are some highlights of recently announced trials in OrthoBio that were picked up by our analysts, posted on SmartTRAK, and included in our Daily Updates email.
 

A 76-pt study is underway evaluating if pts who receive a bioinductive graft (REGENETEN) have better function and fewer re-tear at 1-yr post-op vs those who received a debridement alone. Anticipated completion date is 9/23. clinicaltrials.gov

A 30-pt double blind, randomized, split mouth study was initiated evaluating the non-inferiority of Fibro-Gide in comparison to connective tissue graft for the tx of Miller Class I or II recession defects at 6 mos post tx. clinicaltrials.gov

Find out how to receive SmartTRAK Daily Updates

Continue Reading
12 min read

IFATS 2019: An Interview With The GID Group

By Freddy Buntoum on 2/25/20 8:00 AM

The GID Group – Prepping to revolutionize Regenerative Medicine with an innovative modular tissue processing platform

In December, at IFATS 2019, William “Bill” Cimino, PhD, CEO of The GID Group (GID) sat down with SmartTRAK to discuss the Company’s novel modular tissue processing platform, which reduces an entire GMP cell-processing facility to a single disposable device, enabling physicians to extract and process adipose tissue in real time for use in a wide range of applications.

GID is a privately held, clinical stage cellular medicine company currently working on developing a tissue processing platform, the GID SVF-2 device, that enables cell-based treatments.

To find out more about the GID Group, its revolutionary technology and product candidate, click on the following video to listen to SmarTRAK’s interview with Bill Cimino, recorded live at the IFATS Annual Meeting held in Marseille, France December 3-7, 2019. A transcript of the interview is also provided below.

Continue Reading
8 min read

SmartTRAK Patent Watch - Advanced Wound Care

By Lindsey Wolejko on 2/21/20 10:05 AM

All SmartTRAK subscribers receive a Daily Updates email containing content curated by our analysts, all former marketing, R&D or competitive intelligence professionals with leading medical device companies. The updates contain the latest need-to-know news from earnings calls, conferences, studies, patent filings, new products and more. It's the perfect way to start your day!

Here are some highlights from recent Advanced Wound Care patent filings that were picked up by our analysts, posted on SmartTRAK, and included in the Daily Updates email.
 

S&N was granted US Patent “Apparatus for topical negative pressure therapy” describing a topical negative pressure (TNP) therapy apparatus under the control of negative pressure within a wound dressing. 10,561,769

Mölnlycke’s US Patent Application “CONNECTOR SYSTEM FOR A NEGATIVE PRESSURE WOUND THERAPY SYSTEM” was published describing a connector that allows for the provision of a correct level of negative pressure at the wound site w/ a flexible, safe and convenient system. 20200054804

3M

3M was granted US Patent “Conformable drape cover dressing” relating to a conformable wound dressing system that includes a wound dressing and a dressing support layer. 10,561,536

Find out how to receive SmartTRAK Daily Updates

Continue Reading
4 min read

SmartTRAK's Anne Staylor at the International Stroke Conference 2020

By Lindsey Wolejko on 2/17/20 11:02 PM

Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, will be attending the International Stroke Conference 2020, to be held at the Los Angeles Convention Center, Feb 19-21.

The theme for the conference is A New Era for Stroke Science and Brain Health. According to their website "The International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. This 2½-day conference features more than 1,700 compelling presentations in 21 categories that emphasize basic, clinical and translational sciences and provides the opportunity to network with thousands of colleagues in the stroke field from around the world with wide-ranging expertise and experience."

Continue Reading
5 min read

SmartTRAK Patent Watch - Computer Assisted Surgery

By Lindsey Wolejko on 2/14/20 9:30 AM

All SmartTRAK subscribers receive a Daily Updates email containing content curated by our analysts, all former marketing, R&D or competitive intelligence professionals with leading medical device companies. The updates contain the latest need-to-know news from earnings calls, conferences, studies, patent filings, new products and more. It's the perfect way to start your day!

Here are some highlights from the Computer Assisted Surgery patent filings from January 2020 that were picked up by our analysts, posted on SmartTRAK, and included in the Daily Updates email.
 

Smith & Nephew’s US Patent Application “TECHNOLOGIES FOR INTRA-OPERATIVE LIGAMENT BALANCING USING MACHINE LEARNING” was published describing a system providing real-time sensor data and applying machine learning to determine the next intra-op ligament balancing step. 20200000400

Continue Reading
1 min read

NANS StartUp Spotlight: Micro-Leads Medical

By Lindsey Wolejko on 2/7/20 9:38 AM

Micro-Leads Medical, based in Somerville, MA, showcased HD64, an emerging, high-resolution spinal cord stimulation therapy for treating chronic focal pains of the low-back, trunk, extremities and feet at NANS 2020. Anne Staylor, SmartTRAK's Managing Editor and Sr. Director of Advanced Technologies, attended the NANS 2020 Emerging Technologies Forum and saw this novel technology designed for the spinal cord stimulation market.

Continue Reading
4 min read

Issues in Medtech 2020: Recession, Taxes and Sterilization

By Lisa Mahan on 1/31/20 9:30 AM

The Orthopedic Market experienced healthy growth in H219 fueled by a strong Q319 in the face of difficult comps with the usual fourth-quarter bump due to the seasonality of elective procedures. Looking ahead, several key issues have the potential to impact the US market in 2020. From the economy to taxes, SmartTRAK takes a look at some of the bigger picture issues...

Topics: Orthopedics
Continue Reading
3 min read

SmartTRAK's Anne Staylor at NANS 2020 in Las Vegas

By Lindsey Wolejko on 1/27/20 9:00 AM

Anne Staylor, SmartTRAK's Managing Editor and Director of Advanced Technologies, is in Las Vegas attending NANS 2020, the North American Neurological Society's  23rd annual meeting, and, as you can see from the photo above taken at NANS, she is already thinking about NANS 2021 in Orlando. The theme of the this year's NANS is “Driving Innovation Through Science and Evidence.”  Anne, who covers Neuromodulation for SmartTRAK, will be reporting on the meeting through articles and interviews...

Continue Reading
6 min read

Know Before You Go: NANS 2020

By Thomas Wallick on 1/20/20 4:19 PM

Are you getting ready to head out to Las Vegas to attend NANS 2020 - the North American Neuromodulation Society 23rd Annual Meeting? We sat down with Anne Staylor, SmartTRAK's Managing Editor and Senior Director of Advanced Technologies for our new series, Know Before You Go, to find out what she's looking forward to ahead of NANS 2020.

NANS 2020, billed as the premier meeting in the field of neuromodulation, is being held this year at Caesars Palace in Las Vegas, NV, and will showcase the latest scientific research and technical advancements in neuromodulation.

To hear Anne's take on the upcoming meeting, just click on the following video to listen to the full interview. A transcript of the interview is also provided below the video.

Continue Reading
7 min read

Preventing Incisional Hernias: Mesh vs Better Surgical Skills

By Doug Devens on 1/20/20 9:30 AM

A panel session at ACS Clinical Congress 2019 examines the evidence behind currently proposed techniques to prevent incisional hernias after midline laparotomy closure, including the use of prophylactic mesh and small-bite 4:1 suture closure.

At the American College of Surgeons (ACS) Clinical Congress 2019, there was an important session in which panelists discussed the advantages and disadvantages of using prophylactic mesh after closure of midline laparotomies to prevent incisional hernias. Ajita Prabhu, MD and Benjamin Poulose, MD moderated the panel session on October 28, 2019.

Heidi Miller, MD of University of New Mexico gave background on risk factors for incisional hernias, which she estimated at 12-13% incidence after closure of a laparotomy. She characterized incisional hernias as “mostly due to technical failures,” including poor wound hemostasis or coagulopathy, too much inflammation of the wound and the associated abnormal collagen structure, and sutures without proper tension. With respect to the latter topic, she described how she likes to view the hernia as a chronic wound, with proliferation and remodeling dependent on proper tension of approximation. She also described modifiable risk factors associated with the patient. Smoking and diabetes affect tissue perfusion, with strong data supporting tissue ischemia associated with smoking. Tissue perfusion greatly affects wound healing, as do modifiable factors that affect inflammation, including proper wound care, nutrition (especially vitamin A intake) and obesity, which is associated with chronic inflammation. Additionally, obesity is also associated with increased risk of wound dehiscence and increased mechanical stress tending to open the wound ...

Request a Demo of the SmartTRAK Business Intelligence Portal!

Topics: Wound Care
Continue Reading
4 min read

Q319 Soft Tissue Fixation Market Recap: Steady As She Goes

By Freddy Buntoum on 1/17/20 12:57 PM

Steady as she goes...Soft Tissue Fixation Market on track to achieve SmartTRAK estimates for FY 2019

For the third quarter of 2019, the WW Soft Tissue Fixation Market revenue was up +3.4% YoY. Aggregate growth for the quarter benefited from solid revenue growth in the Hip Labral Repair segment, which was up +10.1% YoY, based on SmartTRAK Financial Dashboard

Focusing on the US region, the Soft Tissue Fixation market was up YoY. However, on a sequential basis, growth was slightly down, attributable to the seasonal nature of Sports Medicine where many surgeries are elective with Q4 generally seeing high procedure volumes. Aggregate growth for Q319 was pulled by notable growths in the Shoulder Soft Tissue Fixation and the Hip Labral Repair segments. Although Knee Soft Tissue Fixation represents the 2nd largest segment, revenue growth was marginal, with the moderate growth seen steady at slightly above  ...

Among the many topics covered in the complete, comprehensive Q319 Soft Tissue Fixation Market Recap*, including all the news, financial data, revenues, charts and SmartTRAK's expert analysis, are:

Topics: Orthopedics
Continue Reading
20 min read

Abbott's Proclaim XR: Extended Battery Life in a Recharge-Free SCS

By Anne Staylor on 1/14/20 12:43 AM

Abbott’s Allen Burton, MD, discusses the Company’s new recharge-free Proclaim XR Neurostimulation System in an interview with SmartTRAK

In the market for Spinal Cord Stimulation (SCS), companies have been looking at different ways to extend the battery life of an implantable pulse generator (IPG) and minimize the amount of time patients spend recharging a device. One competitor that’s making advances in battery longevity is Abbott Laboratories.

Armed with its own research that showed patients do not like recharging, Abbott launched the recharge-free Proclaim Elite SCS in 2017 with a patient-centric strategy and an eye for capturing share in the US SCS market. Since then, there have been questions about battery life, and whether or not a recharge-free IPG would have to be replaced more frequently than a rechargeable SCS.

Request a Demo of the SmartTRAK Business Intelligence Portal!

Continue Reading
4 min read

Meet Stacy Spirito - Director of Sales

By Lindsey Wolejko on 1/10/20 12:55 PM

We are pleased to announce that Stacy Spirito has joined the team at SmartTRAK as Director of Sales. Stacy has spent 14+ years in the medical device and technology industries, most recently as an Account Executive with Gartner, working with Investors.  Prior to that, Stacy was part of a sales team that launched a disruptive new medical device for breast cancer at Mammotome/Leica Biosystems. 

Meet Stacy Spirito:

  1. Stacy, what is your role with SmartTRAK? My role at SmartTRAK is Director of Sales. I will be developing and managing the relationship with our clients and ensuring we are providing value and actionable insights to enable them to deliver on their key initiatives.

Continue Reading
3 min read

Meet Anikó Szekér - Senior Analyst, Wound Care

By Lindsey Wolejko on 1/9/20 9:43 AM

SmartTRAK is pleased to welcome Anikó Szekér, the newest addition to our Wound Care team. Anikó has 10+ years of medical device experience in Wound Care and Surgical single use products. Before joining SmartTRAK, Anikó was  Marketing Manager, Eastern Europe Wound Care and Surgical at Mölnlycke Health Care.

Topics: Wound Care
Continue Reading
8 min read

SmartTRAK Seeking an Enterprise Sales Executive

By Sharon O'Reilly on 1/8/20 12:58 PM

Location: Northeast region of US (NY, NJ, MA, PA)

Full-time Position

Position:

BioMedGPS, a leading strategic advisory and healthcare analytics firm serving the life sciences industry, is seeking a Director of Enterprise Sales with extensive healthcare B2B experience for its SmartTRAK Business Intelligence platform and related products. Applicant must reside in the Northeastern region of the USA for easy access to major accounts.

SmartTRAK is the first business intelligence portal that provides real time data, analytics and curated content by a team of industry experts to help medical device executives make more informed strategic decisions. SmartTRAK is utilized by leading medical device companies within the orthopedic, wound care, regenerative medicine and neuro therapeutic areas. The Director of Sales will be responsible for selling SmartTRAK’s suite of business intelligence solutions to C- suite and other senior level executives, as well as building long term strategic programs and relationships at all levels of the enterprise.

Learn More and Apply

Continue Reading
11 min read

SmartTRAK's Top 10 Blog Posts of 2019

By Sharon O'Reilly on 1/6/20 2:58 PM

It was a busy year, and SmartTRAK, the leading provider of real-time market data, analysis and advisory services for the orthopedic, wound, regenerative medicine and neuro therapies markets, covered all the key industry happenings in 2019, providing comprehensive industry coverage of the latest trends, news, intel and interviews most important to you.

And if you'd like to stay on top of hot trends and technologies in 2020 in the ortho, wound, regen and neuro markets, make sure to sign up to receive a weekly summary of our latest blog posts.

Here are SmartTRAK's Top 10 blog posts of the past year with two bonus posts, because at SmartTRAK we always strive to deliver more than what's expected!

Continue Reading
5 min read

Q319 US Hemostats and Sealants Market Recap: All Companies Post Gains

By Doug Devens on 1/6/20 12:16 PM

The US market for Hemostats and Sealants grew +5.6% YoY in Q319, a continued deceleration from +6.4% YoY in Q219, with fibrin sealants and absorbable hemostats driving the increase.

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market experienced revenue growth in Q319. Leading the way was Becton Dickinson (BD), with IntegraEthicon and Baxter all posting strong gains. The US Hemostats and Sealants market was up +5.6% YoY with all competitors posting gains for the quarter. Sealants continued their solid growth, up +6.5% YoY, with fibrin sealants leading the way. Absorbable hemostats resumed their leadership, contributing to the +5.1% YoY growth to...

Among the many topics covered in the complete, comprehensiveQ319 US Hemostats and Sealants Market Recap* are:

Topics: Wound Care
Continue Reading
4 min read

Q319 SCS Market Recap: Getting Back on Track

By Anne Staylor on 1/3/20 10:03 AM

The SCS market is still down YoY, but improved sequentially as companies get back on track

In Q319, US and WW spinal cord stimulation (SCS) revenues continued to be down YoY against tough comps, but the rate of decline slowed sequentially for most companies as they address ongoing commercial execution issues, customer destocking and initiate new product launches. In the US, SCS revenue was down -4.7% in Q318 according to SmartTRAK Financial Dashboard, an improved sequential growth rate vs a -6.3% YoY decline in Q219. On a WW basis, the SCS market followed a similar pattern, with Q319 revenue of...

Among the many topics covered in the complete, comprehensive Q319 SCS Market Recap* are:

Continue Reading
6 min read

Q319 CAS Ortho Market Recap: Robotics Market Gains Momentum

By Elise Wolf on 12/30/19 10:08 AM

The orthopedic robotics market continues to gain momentum and validation with increasing competition and development milestones being met by key companies in the space.

Topics: Orthopedics
Continue Reading
5 min read

Q319 US Infection Prevention: Antimicrobial Devices Leading the Way

By Susan Paquette on 12/20/19 11:34 AM

Positive gains in the mid-single digits for Q319, a slight decrease from previous quarter

Prevention of HAIs continues to drive measures and practices to reduce Central Line Associated Bloodstream Infections (CLABSIs) and is creating demand for products that can address these issues. In response, numerous programs and educational tools are being launched providing measures and strategies to assist healthcare providers in the prevention and reduction of infection in acute care and other settings.

Last quarter, a coalition of nurses and the AVA launched a drive to support a safety initiative for placing vascular access specialists in every hospital across America. This theme continued at this year’s AVA conference with the mission statement of “Protect the Patient, Educate the Clinician and Save the Line” highlighting the overall focus for the event. Acknowledgment of the importance of the vascular access nurse and team were featured in numerous studies and presentations demonstrating the value of the vascular access team in practice...

Among the many topics covered in the complete, comprehensive Q319 US Infection Prevention Market Recap* are:

Topics: Wound Care
Continue Reading
3 min read

Q319 Trauma Market Recap: Easy YoY Comparisons Support Sequential Gains

By Natasha Weeks on 12/19/19 9:30 AM

Easy YoY comps along with new product introductions help drive sequential growth 

SmartTRAK reports that In Q319, the WW Trauma Market (defined as fixation of the pelvis, femur & proximal/shaft portion of the tibia) increased +3.7% (as reported), with the US posting +4.6% growth. Q319 WW share leaders remained relatively steady compared to last year, with top trauma player DePuy Synthes, followed by Stryker, Zimmer Biomet and Smith & Nephew. The WW Trauma Market Segment shares were...

Among the many topics covered in the complete, comprehensive  Q319 Trauma Market Recap*  are:
Continue Reading
4 min read

Q319 Advanced Wound Care Market: Strong Growth with Slower Growth Ahead?

By Susan Paquette on 12/18/19 9:45 AM

Another quarter of strong growth, but slower growth clouds building up on the horizon here and there. Both Smith+Nephew and ConvaTec have newly appointed CEOs.

For Q319, according to SmartTRAK’s Financial Dashboard, WW Advanced Wound Care (AWC) revenue for Advanced Dressings, External Devices and Biologics was up +5.9% YoY.

Acelity remained the WW AWC market leader, up +6.3% YoY, driven by  Prevena and the Crawford acquisition. WW Advanced Dressings saw several strong shifts in the ranking of companies, with ConvaTec moving up to the 2nd position, surpassing Smith + Nephew (S+N), after ConvaTec recovering, but S+N facing continued declining growth. Mölnlycke led the market and Coloplast was the strongest growing of the top four. The total market was up +3.2% YoY. US Skin/Dermal Substitute (CTP) revenue increased, with xenografts, especially  Organogenesis’  PuraPly, driving gains. WW NPWT was up  +8.2% YoY, with traditional devices up +3.4% and single-use...

Among the many topics covered in the complete, comprehensive Q319 Advanced Wound Care Market Recap* are:

Topics: Wound Care
Continue Reading
2 min read

SmartTRAK Launches New Website!

By Lindsey Wolejko on 12/16/19 7:26 PM

SmartTRAK is excited to announce the launch of their new public website,  SmartTRAK.com. The new SmartTRAK.com features improved functionality,  enhanced custom content and a clean uncluttered design. It also features a more intuitive navigation for current customers and new visitors alike.

Continue Reading
4 min read

Q319 OrthoBio Market Recap: Healthy YoY Growth

By Kim French on 12/16/19 9:30 AM

With a boost from an extra selling day during the third quarter, the US OrthoBio Market continues to be healthy, with Q319 revenue up +5.8% YOY. Year-to-date revenue is up +5.5% compared to the same time period for 2018. In addition to the specific factors that were discussed in the Q219 OrthoBio Recap, the segment’s success may be attributed to robustness in the broader economy and more people feeling comfortable scheduling procedures. As reported in Needham’s Q319 Review, in Q319 vs. Q219, overall orthopedic market growth improved to 5.0% vs. 3.1%, with spine improving to ...

Among the many topics covered in the complete, comprehensive Q319 OrthoBio Market Recap* are:
Continue Reading
4 min read

Q319 Total Joints Market: Improved Pricing & New Products Drive Growth

By Lisa Mahan on 12/13/19 9:30 AM

The US Total Joints Market grew +3.4% in Q319, according to SmartTRAK Financial Dashboard, a sequential improvement over Q2’s 1.8% growth. While the extra selling day in the quarter boosted revenue for most Companies, slightly improved pricing and new product introductions also contributed. Wells Fargo’s Larry Biegelsen estimated recon pricing – based on StrykerZimmer BiometJNJ/DePuy Synthes, and Smith & Nephew– improved to -1.8% YoY. This sequential improvement in growth and pricing is encouraging especially in the face of a difficult comp from Q318 ...

Among the many topics covered in the complete, comprehensive Q319 Total Joints Market Recap* are:

Topics: Orthopedics
Continue Reading
4 min read

Q319 Market Recap: US Surgical Matrices: Tepid Growth

By Doug Devens on 12/12/19 3:48 PM

The US Surgical Matrices Market grew tepidly in Q319,  up +1.2% YoY,  down from its +3.5% growth in Q219. 

The overall US Surgical Matrices market had minimal growth for the quarter at +1.2% YoY, a decline from Q219. The Breast segment contracted -1.5% YoY and a 34.7% share of the entire Surgical Matrices market. The Hernia Repair market continued its modest growth at +2.6% YoY and a 65.3% share of the US Surgical Matrices Market in Q319.

In Q319, Allergan’s hold on the Breast Matrices segment slipped further due to supply chain issues with its AlloDerm ADM, but the Company maintained its leadership of the Surgical Matrices market a 32.3% share. BD continued its growth in their biosynthetic hernia matrices business and maintained No. 2 market position, with revenues of ...

Topics: Wound Care
Continue Reading
3 min read

Q319 Spine Market Recap: Uptick in Procedures Drives Robust US Growth

By Julianne Burns on 12/11/19 9:30 AM

The WW Spine Hardware market saw a return to growth in Q319 with +3.6% growth, the highest growth rate this market has seen in at least 2 years. An uptick in procedure volumes across the board drove robust US market growth of +5.7%. WFS analysts estimate the Q319 Spine market (excluding Infuse) accelerated 90bps sequentially on a stacked two-year basis with Medtronic, Globus and NuVasive taking share from DePuy Synthes, Stryker and Zimmer Biomet.

Topics: Spine
Continue Reading
3 min read

Day 3 Insights From Desert Foot 2019

By Terry Hayslett on 12/7/19 10:54 AM

Whether you are a patient, a provider or product manufacturer it’s difficult to make it through the day without being reminded that healthcare is expensive. Many patients see it in their rising premiums, copays and deductibles. Providers feel it when their reimbursement gets cut or is capped, and product manufacturers experience it when they hear, “it’s too expensive.”

Topics: Wound Care
Continue Reading
3 min read

SmartTRAK's Top 3 Takeaways from Day 2 of Desert Foot

By Terry Hayslett on 12/6/19 9:36 AM

I’ll be the first to admit that I am not a New England Patriots fan. As a matter of fact I get rather irritated when they win year after year. Nevertheless, it’s hard to not appreciate the spirit of teamwork that has propelled the Patriots organization to win six Super Bowl titles. As we know, teamwork does not suggest the absence of conflict; however, it does express the willingness of a group of people, with individual talents, to work together to achieve a goal. Teamwork between clinicians, policy representatives and product manufacturers is crucial to winning the battle of healing wounds, salvaging limbs and saving lives. Three key takeaways from Day 2 of Desert Foot 2019 lend support to this point.

Topics: Wound Care
Continue Reading
2 min read

Desert Foot 2019: Reflections From Day 1

By Terry Hayslett on 12/5/19 10:37 AM

Clinical thought-leaders and product developers convened in the heart of downtown Phoenix, Arizona at Desert Foot 2019 to share knowledge and showcase innovative technologies that aim to improve the quality of life of patients with lower extremity disorders. As a demonstration of the eagerness and commitment to share knowledge, Day 1 began bright and early at 6:00 am with a session highlighting cases in limb preservation and ended at 6:45 pm with a session questioning if there was a resurgence in amputations in patients with diabetic foot. Whether planned or not, this was a thoughtful way to bookend the day by emphasizing the potential good and bad outcomes of this vulnerable patient population...

Topics: Wound Care
Continue Reading
2 min read

Desert Foot 2019: An Interview with Dr. Michael Shore

By Terry Hayslett on 12/3/19 9:47 PM

Ahead of the Desert Foot conference, SmartTRAK interviewed Dr. Michael Shore, Director of Medical Education and a founding member of PRESENT e-Learning Systems, to preview the conference which is being held Dec 4-7, 2019 in Phoenix, AZ

The multi-specialty conference provides comprehensive education for the overall management of the high-risk foot and lower extremities for podiatrists and other clinicians. Attendees will benefit from a wide variety of presentations, hands-on workshops and scientific research and will see cutting edge technology presented by the largest medical device and pharmaceutical companies in the industry.

To find our more about Desert Foot 2019, as well as PRESENT e-learning Systems, click on the following video to listen to SmartTRAK’s interview with Dr. Shore. (16:45 min)

Topics: Wound Care
Continue Reading
3 min read

Know Before You Go: Orthopaedic Summit 2019

By Lindsey Wolejko on 12/2/19 1:45 PM

Are you headed to Vegas for this year’s Orthopaedic Summit (OSET)? We sat down with Kristina Meyer, SmartTRAK’s Senior Analyst for Sports Medicine, for our new series, Know Before You Go, to get the scoop on what she’s looking forward to ahead of the meeting.

OSET will take place December 11-14th at the Bellagio in Las Vegas. The meeting touts itself as the “premier gathering of Total Joint (Knee, Hip, Shoulder), Foot & Ankle, Sports Medicine, Arthroscopic, Spine and Trauma Surgeons, Physician Assistants, Nurse Practitioners, Athletic Trainers, Physical and Occupational Therapists from across the globe.” Orthopaedic Summit 

SmartTRAK’s team is excited to attend and exhibit. Stop by the SmartTRAK booth, #128, to talk with Kristina and the SmartTRAK team about the latest news, trends and intelligence impacting the orthopedic industry.

1. Kristina, you are currently gearing up to attend OSET 2019. What are you looking forward to the most about the meeting?

Topics: Orthopedics
Continue Reading
2 min read

Know Before You Go: Desert Foot 2019

By Lindsey Wolejko on 12/2/19 9:00 AM

Headed to Desert Foot? We have you covered.

SmartTRAK’s Senior Analyst for Advanced Wound Care, Terry Hayslett, is headed to Phoenix, Arizona for the 2019 Desert Foot Conference. We caught up with him ahead of the December 4-7th meeting as part of our new Know Before You Go series.

Desert Foot is one of the premier advanced wound care meetings. The meeting is held annually in Phoenix. “The conference brings together six groups involved with limb salvage preservation of the lower extremity from the Veterans Administration, VA Podiatric Residency Directors, Arizona Podiatric Medical Association, Association for the Advancement of Wound Care (AAWC), the Department of Defense, and healthcare professionals in the private sector, from across the country to a single conference to best meet their educational needs.” Desert Foot

1. Terry, you will soon be attending Desert Foot. What is it about this meeting that you are most excited about?

Topics: Wound Care
Continue Reading
3 min read

CSRS 2019: Highlights and Trends in Spine Research

By Anne Staylor on 11/27/19 1:26 PM

Julianne Burns, SmartTRAK's Senior Analyst, Spine, just returned from attending the 2019 Cervical Spine Research Society's (CSRS) 47th Annual Meeting in New York City.

Julianne discusses highlights from the meeting, including what’s on the horizon for the cervical spine market and the trend toward moving cervical spine procedures to an ASC setting in an interview with SmartTRAK Managing Editor Anne Staylor.

Click the video below to hear the interview, and scroll down to read the transcript.

Topics: Orthopedics
Continue Reading
3 min read

Q319 Extremities Market Recap: New Products Drive Sequential Growth

By Natasha Weeks on 11/27/19 12:04 PM

New products help drive sequential improvement in growth 

The WW Market for Foot & Ankle Fixation exceeded $, up +3.9%, as reported, during Q319, up sequentially due to easy YoY comps. The US Foot & Ankle Fixation market also experienced a sequential increase, resulting in +4.3% reported growth. Major players reported improved growth while smaller players announced new product introductions throughout the quarter.

Stryker posted accelerated trauma & extremities growth in Q319,
reaching $, up +9.3% in the foot & ankle fixation segment according to SmartTRAK Financial Dashboard. The foot & ankle powerhouse reported US growth was positively impacted by double-digit growth across foot, ankle and shoulder products along with the T2 Alpha Nails. Stryker recouped lost share from Q2, gaining ~4.4% share to close Q3 at 25.6%. This gain allowed Stryker to take over the number one position from...

Among the many topics covered in the complete, comprehensive Q319 Extremities Market Recap* are:

Topics: Orthopedics
Continue Reading
2 min read

Q319 US Joint Fluid Market Recap: Essentially Flat

By Freddy Buntoum on 11/25/19 5:39 PM

Single-injection holding the torch in a market essentially flat, impacted by ferocious pricing pressures and declines in multi-injections

For the third quarter of 2019, the US Joint Fluid market revenue was essentially flat, +0.2% vs Q318. Aggregate growth for the quarter was pulled into slightly positive territory by a solid revenue growth of 14.3% YoY in single injection, according to the recently published SmartTRAK Financial Dashboard. However, strength in that segment was barely enough to counter revenue declines in 3- and 5-injections, while the 2-injection segment is still not large enough to make a significant contribution to the overall recovery of the US Joint Fluid market.

The single-injection segment held on to the market lead for Q319. Despite pricing pressure between competitors in this segment, revenue growth further solidifies the trend that the HA market is moving to the lowest treatment cycle.  For Q319, 3-injection products dropped down, strained by heavy competition and a persistent price war. Trailing behind is the 5-injections with...

Among the many topics covered in the comprehensive Q319 US Joint Fluid Market Recap* are:

Topics: Orthopedics
Continue Reading
8 min read

AVA 2019: Key Opportunities for Improvement in Vascular Access

By Susan Paquette on 11/22/19 10:17 AM

AVA Scientific Meeting 2019 highlights key opportunities for improvement in vascular access from process bundles to emerging new products

Introduction

Acknowledgment of the importance of the vascular access nurse and team were obvious at this year’s Association for Vascular Access (AVA) Annual Scientific meeting. When Ramzy Nasrallah took over as CEO for the Association of Vascular Access (AVA) in 2017, he consolidated the mission of AVA “Protect the Patient, Educate the Clinician and Save the Line” to make it more memorable and to create a more powerful message. (See SmartTRAK interview with Nasrallah at AVA 2017). Nasrallah’s ultimate goal for AVA is to be “the biggest, most reputable, and highly regarded healthcare association in the world” with tens of thousands of members globally. Since taking the helm and advancing his agenda...

Topics: Wound Care
Continue Reading
13 min read

Rapid Medical: Innovative Strategies in Stroke Care

By Anne Staylor on 11/14/19 1:10 PM

Rapid Medical CEO Ronen Eckhouse discusses the Company’s latest innovations, the plan for bringing its novel neurovascular devices to market, and Rapid’s strategy for competing in the market for neurovascular devices in an interview with SmartTRAK

To listen to the interview, click on the following video. A transcript of the interview is also provided below, as is a link to download the transcript.

Continue Reading
7 min read

TOBI 2019 Update: Issues & Trends in Orthobiologics

By Freddy Buntoum on 11/11/19 3:56 PM

SmartTRAK's Senior Regenerative Medicine Analyst, Freddy Buntoum, attended TOBI 2019 this summer. Here's a look at some of the key trends and takeaways in Orthobiologics from the 10th PRP & Regenerative Medicine Symposium, hosted by TOBI, that are still prevalent today.

Continue Reading
2 min read

Headed to AAHKS? Here's a Trending Hot Topic!

By Lisa Mahan on 11/6/19 11:30 AM

Headed to AAHKS? Our VP of Content Development for Orthopedics, Lisa Mahan, weighs in on what's trending ahead of the meeting. 

A hot topic at #AAHKS2019 this year will be the move towards outpatient joint replacement surgery with CMS moving to reimburse hospital outpatient total hip replacement and reimbursement of total knee replacement in an ASC setting.
  • Outpatient hip and knee replacement surgeries are expected to comprise 57% of all nonfracture knee and hip replacements by the year 2020. ACS Focus
  • AAHKS currently does not believe CMS has taken adequate action to address issues arising from
Topics: Orthopedics
Continue Reading
4 min read

Total Joints Top Trends to Watch 2019: Care vs Value

By Lisa Mahan on 11/4/19 10:27 AM

At the beginning of the 2019, SmartTRAK looked ahead to the coming year and identified market and technology trends that were likely to shape the Joint Replacement Market landscape in 2019 and beyond. Now that we're approaching the end of the year, here is another look at our predictions.

So what did we see in store for the Total Joints Market? Overall, the theme heading into the new year could be summed up as “Improved Care, Proven Value.” Here are some of the trends we predicted would be worth watching:

Topics: Orthopedics
Continue Reading
3 min read

SNIS 2019: An Interview with Corindus Vascular Robotics

By Anne Staylor on 11/1/19 9:30 AM

Executives from Corindus Vascular Robotics discuss the Company’s plans and strategies for improving stroke care in an interview with SmartTRAK at SNIS 2019

Although Corindus Vascular Robotics is known more for playing in the cardiovascular space, the Company is now leveraging its expertise in vascular robotics to expand into neurovascular applications and telerobotics with the goal of improving access to comprehensive stroke care. The Company’s CorPath GRX System received FDA clearance for percutaneous coronary interventions in 2016 and for peripheral vascular interventions in 2018. Since then, the CorPath GRX has received ...

Continue Reading
5 min read

Orthobiologics: Top Trends to Watch in 2019 and Beyond

By Kim French on 10/28/19 12:19 PM

SmartTRAK predicts Orthobiologic’s top market and technology trends to watch in 2019

At the beginning of the year, SmartTRAK took a look back at 2018 and identified continuing and emerging trends in the market for Orthobiologics that were likely to shape the landscape in 2019 and beyond. Now that we're approaching the end of the year, take another look at our predictions for 2019.

So what did we see in store for Orthobiologics? Here are SmartTRAK’s predictions for the top market and technology trends to watch:

Balancing Sales Growth Trajectory and Portfolio Reshaping

As competition heats up, companies will continue to identify tailwinds and headwinds that sway sales growth and will reshape portfolios accordingly. Sustaining above-market growth rates will take creativity, especially in stagnate markets like spine or in areas that face access challenges. Expect focused efforts around adding/expanding higher growth-higher margin products, shedding lower growth-lower margin product lines and expanding market penetration or margins for the “low-hanging fruit” prospects....

Continue Reading
8 min read

News from AOFAS 2019: Arthrosurface’s New BOSS Toe Fixation System

By Natasha Weeks on 10/16/19 10:00 AM

SmartTRAK Interviews Carl Hasselman, MD about Arthrosurface’s alternative to toe fusions

Arthrosurface showcased its new BOSS Toe Fixation System at the American Orthopaedic Foot & Ankle Society’s (AOFAS 2019) Annual Meeting held September 11–15 in Chicago, IL. Recently 510k cleared, the system improves stabilization in a first metatarsal with a distal bone void. The Boss Toe Screw fills the current product gap in implant solutions for failed synthetic implants. The system provides an option for patients who want to avoid a toe fusion while regaining motion and enjoying an active lifestyle.

To find out more about the new BOSS Toe Fixation System, its benefits, and how it fits in Arthrosurface’s existing line of HemiCAP DF implants and ToeMotion Systems, SmartTRAK interviewed Carl Hasselman, MD, University of Pittsburgh Medical Center, at AOFAS 2019.

To listen to SmartTRAK’s interview with Dr. Hasselman, click on the following video (11:14 minutes). A transcript of the interview is also provided below.

Topics: Orthopedics
Continue Reading
4 min read

Artificial Intelligence for DFUs: An Interview with Dr. Ronald Baxter

By Susan Paquette on 10/14/19 11:40 AM

Dr. Ronald Baxter of Baylor University and Spectral MD, discusses the Spectral MD DeepView Wound Imaging System in predicting DFU wound healing utilizing artificial intelligence in an interview with SmartTRAK.

Spectral MD has developed the DeepView Wound Imaging System to utilize real-time data and artificial intelligence to predict wound healing. The Company has seen initial success in burn treatment and is now moving into validation of their system for diabetic foot ulcers with the goal to predict a wound’s healing potential at the initial clinical visit.

To learn more about Spectral MD’s multi-spectral imaging system, DeepView; the pilot DFU study to analyze the predictive qualities of its artificial intelligence deep learning program, and the company’s plans moving forward, SmartTRAK interviewed Dr. Ronald Baxter, of Baylor University and Spectral MD.

To view the interview, recorded live at SAWC Spring 2019, click on the following video. A transcript of SmartTRAK’s interview with Dr. Baxter is below.

Topics: Wound Care
Continue Reading
2 min read

Insera Therapeutics: An Interview with the Founders

By Anne Staylor on 10/11/19 9:30 AM

Insera Therapeutics takes vacuum aspiration therapy to a new level with a disruptive digital design and cyclical aspiration for mechanical thrombectomy

Insera Therapeutics’ co-founders and brothers Vikram Janardhan and Vallabh Janardhan, MD saw an opportunity in the market for acute ischemic stroke and have developed a next generation, all digital vacuum aspiration system for mechanical thrombectomy designed to take suction aspiration to a new level. Unlike traditional analog electromechanical vacuum aspiration systems, which provide uniform, static aspiration, the Company’s CLEAR Aspiration System allows users to layer cyclical or pulsatile aspiration on top of uniform aspiration. By marrying a computer to a vacuum pump, Insera’s Clear Aspiration System can be finely controlled, and allows users to create their own cyclical wave patterns remotely using an iPad controller.

The Company recently received CE Mark for the Clear Aspiration System with a broad indication beyond stroke, and research to date suggests the technology provides better transmission suction to the tip, improves the first pass effect and decreases emboli in new territory.

To find out more about Insera Therapeutics, the technology and what’s next for the Company, SmartTRAK interviewed CEO Vikram Janardhan and Chief Medical Officer Vallabh Janardhan, MD, at the Society of Neurointerventional Surgery (SNIS) Annual Meeting in Miami Beach, FL held July 22-26, 2019.

Click on the following video to listen to SmartTRAK’s interview with Vikram and Vallabh Janardhan, MD, recorded live at SNIS 2019. To download a transcript of the interview, please click the button at the end of this post.

Continue Reading
1 min read

Before SAWC: Challenges and Opportunities for Wound Care in Assisted Living Facilities

By Lindsey Wolejko on 10/7/19 4:30 PM

SmartTRAK is excited to be attending SAWC Fall 2019, Oct. 12-14 at Caesars Palace in Las Vegas, NV.

Analysts Susan Paquette, VP & GM Wound, BioMedGPS, and Terry Hayslett, Senior Analyst, Advanced Wound Care will be there representing SmartTRAK. Please contact us if you would like to meet.

Susan recently interviewed Bluestone Physician Services’ Sarah Keenan, Chief Clinical Officer, and Jessie Waks, Director of Clinical Practice and Education, discussing challenges and opportunities related to wound care in assisted living facilities. Bluestone Physician Services is a primary care practice delivering on-site care to patients in assisted living and other residential care settings who face difficulty in visiting a physician’s office due to mobility or frailty. If you would like to read the transcript of the interview "Challenges and Opportunities for Wound Care in Assisted Living Facilities: An Interview with Bluestone Physician Services" please click the button at the end of this post.

Continue Reading
16 min read

Cognition Medical: An Interview with CEO Alex Turjman at SNIS 2019

By Anne Staylor on 10/7/19 9:30 AM

Cognition Medical discusses its next generation neurovascular technologies in an interview with SmartTRAK at SNIS 2019

Continue Reading
5 min read

Q219 SCS Market Recap: Shares Shift Amid Ongoing Weakness

By Anne Staylor on 10/4/19 10:00 AM

Despite continued weakness and share shifts in Q219, the SCS market is poised to accelerate in H219 on new products/clinical data

In Q219, US and WW spinal cord stimulation (SCS) revenues were down for all the big players against tough YoY comps and ongoing weakness in the market as companies work through a gap in new product introductions, ongoing commercial execution issues and customer destocking. In the US, SCS revenues were down -6.3% vs Q218 according to the SmartTRAK Financial Dashboard. Although revenues were up sequentially per the usual seasonality in Q2, QoQ growth in Q219 was more anemic compared to the previous year. Between Q119-Q219, US SCS revenue was up just over ...

Among the many topics covered in the complete Q219 SCS Market Recap* are:

Continue Reading
1 min read

Before AVA: Preventing Peripheral IV Failure

By Lindsey Wolejko on 9/30/19 10:17 AM

SmartTRAK is excited to be attending the #AVA Association for Vascular Access 2019 Annual Scientific Meeting taking place October 4-7, 2019 at Caesars Palace in Las Vegas, NV.

Susan Paquette, Vice President and General Manager, Wound, will be representing SmartTRAK at AVA.

Susan has been with SmartTRAK since 2011, leading the Wound efforts. Prior to SmartTRAK, Susan was with 3M for 20+ years' holding leadership positions in new business development, R&D, international and marketing. 

If you would like to meet with Susan for SmartTRAK's insights into the Vascular Access market at #AVA2019, please click to schedule a meeting. To read a SmartTRAK Market Outlook article Susan wrote "Preventing Peripheral IV Failure: The Next Big Thing in Vascular Access" following AVA 2018, click below...

Topics: Wound Care
Continue Reading
4 min read

Q219 CAS Spine Market Recap: Competition Ramping Up

By Elise Wolf on 9/26/19 10:00 AM

Expanding Applications and New Robotic Launches on the Horizon

Enabling technologies in spine surgery continued to gain market acceptance in Q219 given benefits including lower revision rates, ability to market to patients and ability to plan the surgery beforehand, bolstered by several presentations on the benefits of computer-assisted spine surgery at the International Society for Computer-Assisted Orthopaedic Surgery (CAOS) meeting, held in New York City in June. While questions on long-term clinical benefits associated with robotic-assisted surgery remain, CAOS President, Dr. Patrick Meere, believes robotics in spine and orthopedics will continue to gain traction. In SmartTRAK’s interview with Dr. Meere in the article “CAOS 2019: A Synergy of Advanced Technologies,” he noted, “There is not a single venture in the medical field where robotic technologies entered and exited. They have always persisted. There may well be a lag, there may be naysayers, and there may be ...

Among the many topics covered in the complete Q219 CAS Spine Market Recap* are:

Topics: Orthopedics
Continue Reading
4 min read

Before OTA, Read SmartTRAK's Q219 Trauma Report

By Natasha Weeks on 9/23/19 12:20 PM

Trauma segment experiences slight sequential gains as product intros gain traction and companies overcome supply disruption.

The WW Trauma Market ended Q2 posting +1.5% (reported) growth, with the US Market driving growth up 3.6% YOY, slightly up sequentially compared to Q1’s 3.2% gains. Internationally, Europe and ROW fared worse due to missed tenders, with -2.1% and -1.1% growth, respectively. Looking forward, SmartTRAK anticipates the trauma segment will see...

Among the many topics covered in the complete Q219 Trauma Market Recap* are:

Topics: Orthopedics
Continue Reading
4 min read

Q219 US Infection Prevention: Vascular Access Adjunct Products Show Positive Gains

By Susan Paquette on 9/20/19 1:25 PM

Positive gains in the mid-single digits for Q219, a slight increase from previous quarter

Prevention of HAIs continues to drive measures and practices to reduce Central Line Associated Bloodstream Infections (CLABSIs) and create demand for products that can aid in addressing these issues. Numerous programs and educational tools are being launched highlighting measures and strategies for healthcare providers in the prevention and reduction of infection in acute care and other settings.

During the quarter, WHO initiated its annual campaign, SAVE LIVES: Clean Your Hands, to increase global awareness of the importance of hand hygiene among healthcare workers. The campaign recommends an evidence-based approach with demonstrated impact on quality of care and patient safety across all levels of the health system. A call to action is provided along with a range of support materials and implementation tools ...

Topics: Wound Care
Continue Reading
4 min read

H119 Soft Tissue Fixation Market Recap: Solid Growth

By Kristina Meyer on 9/19/19 10:16 AM

Strategy and focus in Sports Medicine for H119

Looking back on the first half of 2019, SmartTRAK reported solid growth, +3.9% in the US and +3.2% WW, across the board in the Soft Tissue Fixation Market. After several years of acquisitions within the Sports Medicine Market, the major players are all able to boast about well-rounded portfolios and the ability to compete in a majority of the Sports Medicine subspecialties. Subspecialty focus, strategy and shifts in market share are now becoming the keys to success in this market. Industry meetings such as American Association of Orthopedic Surgeons (AAOS), Arthroscopy Association of North America (AANA) and American Orthopaedic Society for Sports Medicine (AOSSM) revealed...

Among the many topics covered in the H119 Soft Tissue Fixation Market Recap* are:

Topics: Orthopedics
Continue Reading
4 min read

Q219 Advanced Wound Care Market Recap: Impressive Growth

By Susan Paquette on 9/13/19 10:00 AM

An impressive quarter of growth, driven by CTPs in the US, single-use NPWT globally and a solid performance for Advanced Dressings.

For Q219, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics was up +6.2% YoY. Acelity remained the AWC market leader, while Advanced Dressings saw strong growth from Mölnlycke and Coloplast, offset by weak performance from Smith & Nephew and ConvaTec. The total market reached...

Among the many topics covered in theQ219 Advanced Wound Care Market Recapare:

Topics: Wound Care
Continue Reading
5 min read

Q219 OrthoBio Market Recap: Strong Performance

By Kim French on 9/12/19 10:00 AM

Sales strategy, market reach and evidence-based medicine drives strong Orthobiologics performance

SmartTRAK reports that Q219 performance in the OrthoBio market was strong, up 6% YoY, exceeding SmartTRAK expectations. As expected, Medtronic was the overall OrthoBio market leader, followed by DePuy Synthes and Stryker. Overall, all OrthoBio technologies grew year-over-year except for Spinal Constructs, Soft Tissue Augmentation and Synthetic Cartilage. Although the Spine market has stabilized, Spinal Constructs continues to slowly lose share due to...

Among the many topics covered in the Q219 OrthoBio Market Recap* are:

Topics: Orthopedics
Continue Reading
5 min read

Q219 Extremities Market Recap: Growth Slows

By Lisa Mahan on 9/11/19 9:58 AM

Tough YoY comps, delays and salesforce disruptions slows growth

The WW Market for Foot & Ankle Fixation was up +2.0%, as reported, during Q219, although down sequentially due to tough YoY comps. The US Foot & Ankle Fixation market also experienced a sequential decline in growth. The historically strong segment faced extremely tough YoY comparisons along with no new product launches to spur growth. H119 US growth of...

Among the many topics covered in the Q219 Extremities Market Recap* are:

Topics: Orthopedics
Continue Reading
1 min read

Ahead of OTA, Top Trauma Trends for 2019

By Lindsey Wolejko on 9/9/19 10:00 AM

Ahead of the Orthopedic Trauma Association (OTA) meeting, see what SmartTRAK’s Senior Analyst for Trauma & Extremities, Natasha Weeks, has to say about the latest trends in Trauma.

Natasha recently wrote a fascinating and informative article, "Trauma: Top Trends to Watch in 2019 and Beyond", in which she took a look back at 2018 and identified continuing and emerging trauma trends in the market that are likely to shape the landscape in 2019 and beyond. If you would like to download the article and discover SmartTRAK’s predictions for the top trauma market trends to watch, just click the button below.

Download the "Trauma: Top Trends to Watch" Article

Continue Reading
5 min read

Q219 US Hemostats & Sealants Market Recap: Slightly Lower Growth YoY

By Doug Devens on 9/6/19 11:31 AM

The US market for Hemostats and Sealants grew +6.4% YoY in Q219, a slightly lower growth rate vs Q119, with biologic sealants and thrombin hemostats driving the increase.

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the US Hemostats and Sealants market, except Ethicon, experienced revenue growth in Q219. Leading the way was Baxter, as it capitalized on Ethicon’s supply problems with SurgifloCryolife and Becton Dickinson (BD) both posted strong gains. Ethicon still continued to dominate the overall US Hemostat and Sealants market, with a 40.7% share, down from 48.6% share in Q119. Most of this share shifted to Baxter as the Company continues to chip away at...

Among the many topics covered in the Q219 US Hemostats and Sealants Market Recap* are:

Topics: Wound Care
Continue Reading
4 min read

Q219 US Surgical Matrices Market Recap: Modest Growth

By Doug Devens on 9/5/19 9:54 AM

The US Surgical Matrices Market continued its modest growth in Q219, with growth in breast matrices continuing to outpace hernia matrices.

SmartTRAK reports that the US Surgical Matrices market, comprised of matrices used for Breast Reconstruction and Hernia Repair, experienced single digit growth in Q219 according to SmartTRAK estimates. The fast-growing Breast Reconstruction segment slowed to +4.6% YoY during the quarter, while the US Hernia Repair market ticked up slightly to +2.9% YoY.

Among the many topics covered in the Q219 US Surgical Matrices Market Recap* are:

Continue Reading
3 min read

Meet Nate Greenlee, Product Director

By Lindsey Wolejko on 8/28/19 10:05 AM

Nate Greenlee has joined the SmartTRAK team as Product Director. Nate has 20+ years experience as a startup founder and executive. Before joining SmartTRAK, Nate helped launch software, big data and new space companies, spanning the financing gamut from bootstrapped, angel-funded and VC funded companies, including Space Adventures, LTD., which  has currently sold over $500 Million in Private Space Flights to the International Space Station.

Continue Reading
4 min read

Q219 Total Joints Market Recap: Hips Drive Acceleration

By Lisa Mahan on 8/26/19 1:01 PM

Hips drive slight acceleration in TJR Market while Knees held steady

With two earnings seasons of 2019 behind us, US Total Joints Market growth of 1.7% for H119, as modeled by SmartTRAK Financial Dashboard, is trending below SmartTRAK projections of 2.6% growth for FY19. This trend is not surprising considering the heightened seasonality we’ve seen over the last few years in H2 due to high patient deductibles. US Total Joints Market growth strengthened slightly to 1.8% for Q219 compared to 1.6% in Q1 driven by...

Among the many topics covered in the Q219 Total Joints Market Recap* are:

Topics: Orthopedics
Continue Reading
3 min read

Meet Rachel Dolan - Corp. Enterprise Solutions Manager

By Lindsey Wolejko on 8/22/19 10:00 AM

Rachel Dolan is SmartTRAK's new Corporate Enterprise Solutions Manager. Rachel has 5+ years in the sports medicine and medical device industries, most recently serving as Account Manager for Stryker Medical working with all organizational levels of hospital customers.

Meet Rachel Dolan:
  1. What is your role with SmartTRAK? I am the Corporate Enterprise Solutions Account Manager. I’m responsible for managing and developing client accounts to initiate and maintain favorable relationship with clients.
Continue Reading
1 min read

Join SmartTRAK, DSM and MCRA for Breakfast with an Executive Panel Discussion

By Lindsey Wolejko on 8/20/19 7:59 PM

Join SmartTRAK for breakfast and an Executive Panel on “Advanced Technologies: Shifts in the Spine Landscape” at McCormick Place in Chicago, IL on Sept 26th. A panel of experts will be on hand to discuss the latest in advanced technologies, interbody devices, materials and design, and the impact these changes pose from an FDA regulatory standpoint.

Date:              Thursday, September 26th, 2019
Time:              7:30am-8:30am
Location:      Hyatt Regency McCormick Place,  Chicago, IL
Room:            Jackson Park C&D

Panelists include:

Continue Reading
4 min read

Q219 US Joint Fluid Market Recap: Marginal Revenue Growth

By Freddy Buntoum on 8/12/19 8:55 AM

Q219 saw marginal revenue growth amid single-injection momentum and competitive pricing pressure

The numbers are in and now that we are in the second quarter of 2019, the US Joint Fluid market seems to be getting off its slow-ish start of the year, gaining some momentum with the single-injection segment pushing the aggregate total revenue into positive growth, according to the recently published SmartTRAK Financial Dashboard. This, despite relentless and fierce pricing competition in the multi-injection arena. 

Among the many topics covered in the Q219 US Joint Fluid Market Recap* are:

Topics: Orthopedics
Continue Reading
2 min read

Orthofix Cites SmartTRAK in Q219 Earnings Call and Press Release

By Lindsey Wolejko on 8/8/19 11:01 AM

SmartTRAK was once again cited as a trusted source for market data, this time in the Orthofix Q219 Earnings Call and press release.

Brad Mason, Orthofix's President and Chief Executive Officer, referenced the SmartTRAK Market Recap: OrthoBio Report in the press release and stated “Regarding the second quarter results, net sales were in line with our expectations, led by another quarter of outstanding performance in our Biologics products and notably, as reported by SmartTRAK ®, Orthofix now has the number one market share position in the U.S. cellular allograft segment.”
Topics: Orthopedics
Continue Reading
3 min read

Meet Terry Hayslett Senior Analyst Advanced Wound Care

By Lindsey Wolejko on 8/1/19 12:42 PM

Terry Hayslett is SmartTRAK's Senior Analyst, Advanced Wound Care. Terry has 20+ years of diverse healthcare experience, including provider reimbursement, corporate compliance, business development, strategic planning, financial analysis and health economics. Before joining SmartTRAK, Terry was  responsible for the global funding and reimbursement function at Mölnlycke Health Care. 

As a Senior Analyst for Wound Care, Terry will manage and maintain the US & WW External Devices (NPWT, Energy, Oxygen and Debridement) and Compression modules and provide reimbursement and regulatory support across all AWC modules.

Meet Terry Hayslett:

1. What is your role with SmartTRAK? As a Senior Analyst for Wound Care, my role is to manage and maintain the US & WW External Devices (NPWT, Energy, Oxygen and Debridement) and Compression modules. I also provide reimbursement and regulatory support across all AWC modules.

Continue Reading
12 min read

EWMA 2019: Insights and Innovation in Advanced Wound Care

By Susan Paquette on 7/30/19 10:00 AM

SmartTRAK analysts Susan Paquette and Lennart Stadler on European market trends and emerging products and technologies showcased at EWMA 2019.

In many ways, the European Wound Management Association (EWMA) annual meeting is a microcosm of the latest wound care trends in Europe and provides a glimpse of what’s on the horizon in the worldwide (WW) market for Advanced Wound Care (AWC).

Topics: Wound Care
Continue Reading
3 min read

SmartTRAK is Seeking a European Wound Care Analyst

By Lennart Stadler on 7/29/19 6:00 AM

The SmartTRAK analyst team is expanding and we are looking for an experienced and motivated individual who would like to manage one or more of our Advanced Wound Care modules, with a focus on the European markets. As you know, all of our SmartTRAK analysts are former marketing, business development or competitive intelligence professionals with one of the major medical device manufacturers and, in fact, most have come to us via recommendations from our subscribers. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add to the SmartTRAK platform.

Learn More and Apply

Continue Reading
2 min read

More SmartTRAK Updates Email Customization Options!

By Lindsey Wolejko on 7/29/19 5:00 AM

SmartTRAK Subscribers: See only news for the Markets, Modules and Segments and now TYPES of content that you care about!

Have you ever wished that you could customize your SmartTRAK Daily Updates Email so that you can see ONLY news about the SmartTRAK Markets, Modules & Segments as well as Type of content that you care about (like skipping all the Patent updates)?

And that you could save yourself time from scrolling through all the Markets, Modules and Segments that your company subscribes to? 

Continue Reading
1 min read

Smith & Nephew Cites SmartTRAK in Meniscal Knee Repair Press Release

By Kristina Meyer on 7/22/19 1:51 PM

SmartTRAK was cited once again as a trusted source for data in a press release from Smith & Nephew entitled "Smith & Nephew meniscal knee repair technology delivers 0% re-operation rate and 100% meniscal healing at six months shows first ever study of horizontal cleavage tears".

Continue Reading
5 min read

Robotics Front and Center at the Orthopedic Design & Technology Forum

By Lindsey Wolejko on 7/19/19 9:00 AM

Robotic-assisted surgery was a hot topic of discussion at this year’s ODT Forum. SmartTRAK Senior Analyst for Computer-Assisted Surgery, Elise Wolf, participated in a panel discussion entitled “Tech Talk: An Overview of the Growing Role of Additive Manufacturing and Robotic Surgery,” along with Mitch Foster, CEO of Mindset Medical and former CEO and Co-Founder of Excelsius Surgical. The session was moderated by Dawn Lissy, President & Founder of Empirical Testing.

The discussion focused on current market dynamics and future directions in robotic platforms and other enabling technologies in orthopedic and spine surgery. An excerpt of the panel discussion is provided below.
Topics: Orthopedics
Continue Reading
1 min read

SmartTRAK Attending SNIS 2019

By Lindsey Wolejko on 7/18/19 11:56 AM

SmartTRAK is excited to be attending the Society of Neurointerventional Surgery’s (SNIS) 16th Annual Meeting in Miami, Florida from July 22-25, 2019. Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be covering the latest news at the conference, and will be providing updates on key studies, trends, and technologies affecting the market for ischemic and hemorrhagic stroke devices. 

Continue Reading
1 min read

SmartTRAK Makes the OCBJ’s List of Largest Women-Owned Firms

By Lindsey Wolejko on 7/15/19 10:00 AM

BioMedGPS, developer of SmartTRAK Business Intelligence, has been recognized by the Orange County Business Journal (OCBJ) as one of the largest women-owned firms in Orange County, CA.

Continue Reading
3 min read

2019 Spine Market Outlook: What to Expect This Year

By Julianne Burns on 7/11/19 10:37 AM

SmartTRAK identifies trends to watch in Spine

By most accounts, the Spine market has stabilized with modest low single-digit growth expected this year. Medtronic CEO Omar Ishrak agrees that the Spine market seems to have stabilized and is starting to inch back up. However, he suggests that it is still slower than a year or two ago as price declines are now offsetting procedure growth, resulting in flat to low single-digit to growth. For 2019, Needham analysts are modeling 2% spine market growth with overall orthopedic market growth of 3.4%.

Topics: Orthopedics
Continue Reading
2 min read

BioMedGPS SmartTRAK Partners with Quomeda

By Lindsey Wolejko on 7/8/19 6:00 AM

New strategic alliance expands SmartTRAK market research capabilities

BioMedGPS, developer of SmartTRAK Business Intelligence, is excited to announce a new strategic partnership with Quomeda, a widely respected international healthcare research consultancy firm located in the UK.  Through this new alliance, SmartTRAK has expanded its suite of strategic advisory services globally to include custom consulting as well as provider, hospital and procedural volume data.
Continue Reading
2 min read

SmartTRAK at EWMA 2019

By Thomas Wallick on 6/24/19 4:22 PM

SmartTRAK hosted a tour, dinner reception and briefing at Gothenburg's Universeum before EWMA 2019. Attendees were treated to a private tour of the Universeum and the Ocean Zone prior to dinner and the briefing, entitled Trends, Opportunities and Innovations in Advanced Wound Care, with a special focus on the European market.

Continue Reading
4 min read

AAOS 2019: An Interview with OrthogenRx CEO Michael Daley

By Freddy Buntoum on 6/14/19 10:29 AM

OrthogenRx CEO & Founder Michael Daley talks about the Company’s new 3-injection HA product, TriVisc and what will come next.

Michael Daley, CEO & Founder of OrthogenRx, a US medical device company focused on treatments for musculoskeletal conditions, talked about TriVisc, the Company’s new 3-injection hyaluronic acid (HA) product for knee osteoarthritis, as well as the future at OrthogenRx, in an interview with SmartTRAK at the American Academy of Orthopaedic Surgeons 2019 Annual Meeting held March 12-14, 2019 in Las Vegas, NV.

What is the rational for OrthogenRx to bring TriVisc now to a very crowded 3-injection HA segment?

To have a presence in the entire US HA market, OrthogenRx aims to provide...

Continue Reading
3 min read

Meet SmartTRAK's Elise Wolf at CAOS 2019 in New York City

By Sharon O'Reilly on 6/10/19 3:47 PM

Elise Wolf, SmartTRAK's Senior Analyst, Computer Assisted Surgery, will be representing SmartTRAK at CAOS International 2019, the 19th Annual Meeting of the  International Society for Computer Assisted Orthopaedic Surgery, to be held in New York, June 19-22 at the Midtown Hilton.

Elise, with bachelor's and master's degrees in bioengineering, designed biologically inspired robots for the Department of Defense at a spin-off of Carnegie Mellon University. After robotics, she transitioned to the medical device industry and has more than 15 years of experience in product development, marketing, and business development consulting in emerging medical device technologies and orthopedics. Elise has worked with BioMedGPS since 2009 as a SmartTRAK Senior Analyst covering orthopedics and Computer-Assisted Surgery.

You can view Elise's intro video below...

Continue Reading
2 min read

Meet SmartTRAK's Freddy Buntoum at TOBI 2019 in Chicago

By Sharon O'Reilly on 6/6/19 5:00 PM

Frederique Buntoum (aka Freddy), SmartTRAK's Senior Analyst, Regenerative Medicine, overseeing the Cell Processing, Amniotic Tissue and Joint Fluid modules, will be representing SmartTRAK at TOBI 2019, the Tenth Annual PRP & Regenerative Medicine Symposium in Chicago, IL, June 6-8. 

You can view Freddy's intro video below...

Continue Reading
8 min read

3M/Acelity: A Deeper Look Into the Potential Deal

By Terry Hayslett on 5/31/19 3:00 PM

SmartTRAK examines what the combined company will look like in terms of revenue, product portfolios, financial performance and more.


In its biggest deal to date, 3M recently announced the acquisition of wound care giant Acelity and its KCI subsidiaries for $6.7B, a move that propels 3M to the top of the Advanced Wound Care (AWC) market when the deal closes in H219.

Topics: Wound Care
Continue Reading
4 min read

Artificial Intelligence for DFUs: An Interview with Dr. Ronald Baxter of Spectral MD

By Susan Paquette on 5/30/19 11:20 AM

Dr. Ronald Baxter of Baylor University and Spectral MD, discusses the Spectral MD DeepView Wound Imaging System in predicting DFU wound healing utilizing artificial intelligence in an interview with SmartTRAK.

Spectral MD has developed the DeepView Wound Imaging System to utilize real-time data and artificial intelligence to predict wound healing. The Company has seen initial success in burn treatment and is now moving into validation of their system for diabetic foot ulcers (DFUs) with the goal to predict a wound’s healing potential at the initial clinical visit.

To learn more about Spectral MD’s multi-spectral imaging system, DeepView; the pilot DFU study to analyze the predictive qualities of its artificial intelligence deep learning program, and the company’s plans moving forward; SmartTRAK interviewed Dr. Ronald Baxter, of Baylor University and Spectral MD.

A transcript of SmartTRAK’s interview with Dr. Baxter is below. To view the interview recorded live at SAWC Spring 2019, click on the following video.

Topics: Wound Care
Continue Reading
4 min read

Q119 Total Joints Recap: Market Benefits from Easier Comps

By Lisa Mahan on 5/29/19 9:30 AM

As surgeries get pushed to later in the year, growth against easier comps does not signal market strengthening

The US Total Joints Market, which comprises approximately 55% of the global market, experienced stronger growth YoY, up+1.6% for Q119 compared to -0.8% in Q118, according to SmartTRAK Financial Dashboard. Growth also increased sequentially from Q418’s 1.5%.

The market benefited from easier comps against Q118’s nasty flu season which prompted hospitals across the US to postpone surgeries. But SmartTRAK does not believe the bump in growth in the face of easy comps signals a strengthening recon market. Looking back on a 2-yr basis, the market appears to have decelerated 50 bps which suggests an accompanying slow down in the number of procedures taking place early in the year. Wells Fargo’s Larry Biegelsen speculates that...

Among the many topics covered in the Q119 Total Joints Market Recap are:

Topics: Orthopedics
Continue Reading
6 min read

AAOS 2019: Arthrosurface Working to Stand Out in Shoulder Arthroplasty market

By Lisa Mahan on 5/27/19 10:09 AM

SmartTRAK interviews Arthrosurface CEO Steve Ek about the Company’s newest shoulder system, the OVOMotion, and what differentiates it from other current and emerging shoulder systems

The orthopedic industry has sharpened its focus on value-based care. Health care providers are looking for technologies that maximize care, reduce costs and increase efficiencies, while patients are seeking affordable treatment options that will restore their function and improve their quality of life.

At the 2019 American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting, Arthrosurface CEO Steve Ek, Dr. Greg Nicholson, Rush University Medical Center, and Dr. Anthony Miniaci, Cleveland Clinic, discussed the Company’s newest shoulder implant system, the OVOMotion stemless shoulder, and its value proposition for both health care providers and patients in an interview with SmartTRAK.

(This is Part 2 of SmartTRAK’s interview with Arthrosurface. Be sure to see Part 1 - "Arthrosurface Takes Aim at Patellofemoral Pain" - in which Arthrosurface discusses their new patellofemoral joint implant, the Wave Kahuna.)

Topics: Orthopedics
Continue Reading
1 min read

SmartTRAK Seeking a European Wound Care Analyst

By Lennart Stadler on 5/23/19 12:57 PM

The SmartTRAK analyst team is expanding and we are looking for an experienced and motivated individual who would like to manage one or more of our Advanced Wound Care modules, with a focus on the European markets. As you know, all of our SmartTRAK analysts are former marketing, business development or competitive intelligence professionals with one of the major medical device manufacturers and, in fact, most have come to us via recommendations from our subscribers. We believe that having a person of this caliber with relevant experience and deep insight on the market is a tremendous value-add to the SmartTRAK platform.

Learn More and Apply

Continue Reading
15 min read

Intraoperative Neuromonitoring in SCS: An Interview with Steven Falowski, MD

By Anne Staylor on 5/22/19 9:30 AM

Intraoperative neuromonitoring could be a game changer in the field of SCS by elucidating the MOA for current and emerging SCS waveforms and stimulation patterns. But will it improve outcomes? To find out more, SmartTRAK interviewed Steven Falowski, MD at NANS 2019.

Steven Falowski, MD, Secretary of the Board for the North American Neuromodulation Society (NANS), discusses the latest research on the use of intraoperative neuromonitoring during spinal cord stimulation (SCS) in an interview with SmartTRAK at the NANS 22nd annual meeting held Jan. 17-20, 2019 in Las Vegas.

Historically, pain specialists have always placed spinal cord stimulators in awake patients for safety reasons and to confirm the therapy is adequately covering painful areas. However, Dr. Falowski says there’s been a paradigm shift where both pain physicians and surgeons alike are now using intraoperative neuromonitoring to place SCS systems for both percutaneous electrodes and paddle leads in asleep patients to more accurately localize the spinal cord midline and to improve intraoperative electrode placement and pain coverage... 

Continue Reading
4 min read

Q119 Joint Fluid Market: Revenues Down, Pricing Pressures and FDA Scrutiny

By Freddy Buntoum on 5/20/19 4:42 PM

Revenues down again, competitive pricing pressures remain, market is under FDA scrutiny

After a sluggish start of the year, the US Joint Fluid market gained steam during the quarter as demand and volumes picked up in several market segments in spite of intense competitive pricing pressures. Revenues were within SmartTRAK’s projected range with a marginal decline of -0.3% YoY according to the recently published SmartTRAK Financial Dashboard.

For Q119, the 3-injection segment accounted for 44.6%  of the US Joint Fluid market, followed by single-injection products at 41.5%, the 5-injection segment at 12.9% and rounding up the market with the 2-injection segment at 1.1%, according to SmartTRAK Financial Dashboard results. The single-injection segment showed good recovery from last year driven by increased adoption of newer products and/or sales expansion measures by some suppliers. The 3-injection segment was down in the low single digits during Q119 owing to continued and fierce pricing competition. The 5-injection segment showed no reprieve from its downward trend, declining...

Among the many topics covered in the Q119 US Joint Fluid Market Recap are:

Topics: Orthopedics
Continue Reading
16 min read

INS 2019 Preview: An Interview with INS President Robert Levy, MD

By Anne Staylor on 5/20/19 12:59 PM

In an interview with SmartTRAK, Robert Levy, MD, president of the International Neuromodulation Society (INS), provides a preview of the research, emerging technologies, and trends in neuromodulation that will be at the INS 2019 14th World Congress to be held May 23-30, 2019 in Sydney, Australia. 

The meeting will highlight several important topics, including the use of neurostimulation to reduce opioid use, closed-loop neurostimulation, and advances in non-invasive brain stimulation, including for the treatment of post-traumatic stress disorder, depression, and for enhancing memory and learning.

In terms of research, Dr. Levy said Sam Eldabe, MD of the United Kingdom will provide a critical evaluation of clinical trials in neuromodulation. Researchers will also present the latest insight into mechanism of action, new data on neurostimulation for cardiac ischemia, as well as research on use of deep brain stimulation (DBS) for obesity, eating disorders and addiction. Researchers will also present important pivotal trial results, including: the Evoke Study (Saluda Medical), evaluating closed-loop spinal cord stimulation (SCS); the SURF study (Stimwave Technologies), comparing different wireless SCS frequencies and waveforms; and the ReActiv8 trial (Mainstay Medical), evaluating the use of a restorative neurostimulation system for nocioceptive chronic low back pain. 

On the technology front, the INS’s Innovation Day will highlight disruptive innovations in neuromodulation, and will feature panel discussions and presentations by researchers and major shareholders from early stage start-ups, middle-stage start-ups and well-established companies.

To find out more about the INS World Congress, click on the following video to listen to SmartTRAK’s interview with Dr. Levy recorded via phone from his office in Florida. A transcript of the interview is also provided below.

Continue Reading
4 min read

AAOS 2019: Arthrosurface Takes Aim at Patellofemoral Pain

By Lisa Mahan on 5/20/19 9:00 AM

SmartTRAK Interviews Arthrosurface CEO Steve Ek about new WaveKahuna PFJ Implant

Arthrosurface hopes to expand the market for joint arthroplasty with a novel patellofemoral arthroplasty implant and five-year data demonstrating long-term clinical benefits for treating patients with patellofemoral pain earlier in the treatment continuum, with evidence suggesting that it halts the progression of osteoarthritis (OA).

Today, many of these patients fall into a treatment gap. As much as 22% of the US population could be suffering from patellofemoral pain, according to a recent analysis of data from 23 studies. PLoS One Many orthopedic surgeons remain unconvinced that surgical management is of long-term benefit. Instead they choose to manage these patients with conservative treatment until they become candidates for joint replacement.

To find out more about the Company’s new patellofemoral arthroplasty implant, the WaveKahuna, and how it can address surgeon concerns about long-term clinical benefits, SmartTRAK interviewed Arthrosurface CEO Steve Ek, and Gregory Nicholson, MD, Rush University Medical Center at the 2019 American Academy of Orthopaedic Surgeon’s (AAOS) Annual Meeting held March 12-16 in Las Vegas, NV.

Topics: Orthopedics
Continue Reading
4 min read

Top 10 Things To Do in Gothenburg Sweden While at EWMA

By Thomas Wallick on 5/15/19 10:54 AM

Beautiful Gothenburg, Sweden is hosting EWMA 2019 - the European Wound Management Association conference, on June 5-9.

Gothenburg, Sweden's second largest city after Stockholm, located on the coast in southwestern Sweden, is considered "the quintessential 'second city': understatedly hip and unexpectedly vibrant with neoclassical architecture lining its tram-rattled streets, locals sunning themselves beside canals, and always an interesting cultural or social event going on."

Here are some of SmartTRAK's top things to do when taking a break from the conference. And we know what we're talking about - SmartTRAK's Senior Analyst, Advanced Wound Care, Lennart Stadler lives there!

Continue Reading
1 min read

SmartTRAK Hosts Pre-EWMA Event at Gothenburg's Universeum Aquarium

By Susan Paquette on 5/13/19 11:34 AM

IRVINE, CALIF. (PRWEB) 

BioMedGPS is excited to host its subscribers and guests on Tuesday, June 4th, at a very special Pre-EWMA 2019 event at Gothenburg’s Universeum Aquarium.

SmartTRAK will be hosting an exclusive Private Event Pre-EWMA at Gothenburg’s Universeum Aquarium. Guests will be treated to an aquarium tour, dinner and briefing on the latest Trends, Opportunities and Innovations in Advanced Wound Care.

SmartTRAK’s Advanced Wound Care Experts will serve as panelists. Susan Paquette - SmartTRAK VP & General Manager, Wound - will be providing overall insights on the wound market and Lennart Stadler - SmartTRAK Senior Analyst, Advanced Wound Care - will be presenting data on important trends and innovations.

Continue Reading
3 min read

Spine Acquisition Update

By Julianne Burns on 5/10/19 6:47 PM

Med device giants are scooping up innovative technologies

The Spine market is bustling with activity so far this spring, with two notable acquisitions hot off the press.

Medtronic announced its acquisition of Titan Spine,  strengthening Medtronic's interbody position with Titan Spine's portfolio, which consists of a full line of titanium, surface-enhanced interbody fusion devices featuring Titan’s nanoLock surface technology. The acquisition is expected to close during Medtronic's first fiscal quarter ending July 26, 2019, although terms of the deal were not disclosed. Titan Spine currently markets its line of Endoskeleton interbody devices in the US, Europe and Australia. This acquisition further validates the shift in the interbody market from PEEK to porous titanium. Medtronic already offers interbodies manufactured from Ti-coated PEEK (Pure Titanium Coating or PTC) and just last year launched a titanium 3D printed platform – TiONIC Technology - that enables more complex designs and integrated surface technologies for spine surgery implants.

Topics: Orthopedics
Continue Reading
2 min read

SmartTRAK Cited in 3M's Acelity Acquisition Press Release

By Susan Paquette on 5/10/19 4:04 PM



SmartTRAK, the leading source of competitive intelligence used by the top ten global orthopedic & wound care companies, was cited as a source in 3M's presentation "3M to Acquire Acelity Inc." published on May 2.

Topics: Wound Care
Continue Reading
1 min read

SAWC 2019 From the Floor

By Rebecca Gonzalez on 5/10/19 11:59 AM

#SAWC2019 in San Antonio is fantastic! So many things to do and see. Stay tuned for articles from SmartTRAK with updates and highlights. In the meantime, a few photos!

Topics: Wound Care
Continue Reading
9 min read

DSM Biomedical's Material Contribution to the Wound Care Market - SmartTRAK Interviews Raoul Verheggen

By Susan Paquette on 5/8/19 6:30 PM


SmartTRAK talks with Raoul Verheggen, Global Product Director for DSM Biomedical, regarding the Company’s recent foray into the wound care space and how its addressing unmet needs for patients and businesses

Novel materials and components are key to innovative wound care products that provide superior patient outcomes. DSM Biomedical is a B2B supplier whose business it is to provide these unique components to the medical device industry. SmartTRAK talks with Raoul Verheggen of DSM Biomedical, Global Product Director for Wound, about the company, their capabilities and plans moving forward in support of wound care. A transcript of the interview is below. To listen to the interview recorded via Uberconference, click on the following video. 

Topics: Wound Care
Continue Reading
2 min read

NANS 2019: Highlights and Key Takeaways

By Anne Staylor on 5/7/19 7:30 AM

SmartTRAK highlights key takeaways from the recent North American Neuromodulation (NANS) 22nd annual meeting held in Las Vegas in January, including important company news, trials, technologies, and trends affecting the US market for spinal cord stimulation (SCS) and what's next in this market. This informative article also includes exclusive interviews with leading figures in Neuromodulation including Saluda Medical CEO John Parker, President Abbott Neuromodulation Keith Boetigger, Medtronic Senior VP and Pain Therapies President Marshall Stanton, and Medtronic Senior Global Product Manager for Pain Stimulation and Early Interventions Brian Ranck ...

Continue Reading
3 min read

SmartTRAK's Q418/FY18 Trauma Market Recap

By Natasha Weeks on 5/1/19 1:07 PM

Sequential improvement despite tough comps, supply disruption and pricing pressure

Topics: Orthopedics
Continue Reading
1 min read

SmartTRAK’s Elise Wolf Provides Robotics Expertise at ODT Forum

By Sharon O'Reilly on 4/29/19 2:00 PM



BioMedGPS’s SmartTRAK Senior Analyst for Computer-Assisted Surgery, Elise Wolf, participated as an expert on robotics in a panel discussion entitled “Tech Talk: An Overview of the Growing Role of Additive Manufacturing and Robotic Surgery” at the ODT Forum (Orthopedics Device & Technology Forum) in Memphis, TN on April 11th. The panel, facilitated by Dawn Lissy, President of Empirical Testing, also included spine robotics entrepreneur Mitch Foster, CEO of Mindset Medical and former CEO of Excelsius Surgical, a surgical robotics technology company that was acquired by Globus Medical in 2013. Brian McLaughlin, CEO of Amplify, an additive manufacturing startup specializing in foot and ankle implants, and Chuck Hansford, Director of Advanced Materials Processing at Tecomet, participated in the discussion on additive manufacturing...

Topics: Orthopedics
Continue Reading
3 min read

Q418/FY18 Soft Tissue Fixation Market Recap

By Kristina Meyer on 4/29/19 11:29 AM

The top Sports Medicine competitors are making moves

The consolidation within the Sports Medicine market over the past four years has allowed several of the top players to build upon their growing portfolio and make moves within the market.  While Arthrex continues to lead with innovation, Smith and Nephew is focused on the healing capabilities within its shoulder portfolio.  New-ish CEO Namal Nawana has set the tone of acquisitions across all of SNN’s franchises to enhance SNN’s portfolio and fill gaps in their bag. Stryker is reaping the benefits of their acquisitions and becoming a viable competitor in the hip arthroscopy market.  Zimmer Biomet and CONMED appear to be making a comeback in the Sports market with strong leadership, consistency and a launch into new areas of Sports Medicine...

Among the many topics covered in the Q418/FY18 Soft Tissue FixationMarket Recap are:

Topics: Orthopedics
Continue Reading
2 min read

SAWC Fall 2018: Novel Compression Garment for Complex Edema

By Susan Paquette on 4/24/19 10:00 AM

SmartTRAK highlights the latest research on Sigvaris SECURE presented at SAWC Fall

A novel hybrid compression garment offers promise for patients with difficult-to-treat chronic edema according to an 11-patient case series presented at SAWC Fall. Patients with chronic edema, including lymphedema, are challenged in finding compression garments that are clinically efficacious, cosmetically appealing and comfortable to wear. The 11-patient case series evaluated Sigvaris’ recently launched SECURE, an innovative new Compression and Containment Hybrid (CCH) garment that combines the comfort of circular knit garments and the stiffness traditionally provided by thicker textiles, inelastic wraps or flat knit garments. The new hybrid circular knit garments are thin, cosmetically appealing, and meet the clinical requirement of chronic edema management – graduated compression and containment.

Topics: Wound Care
Continue Reading
3 min read

Q418/FY18 Advanced Wound Care Market Recap

By Susan Paquette on 4/18/19 9:30 AM

Dressings recover Q418, all segments showing solid gains

For FY18, according to BioMedGPS’ SmartTRAK Financial Dashboard, WW Advanced Wound Care (AWC) revenues for Advanced Dressings, External Devices and Biologics were up +4.1% YoY. Acelity remains the global market leader followed by S&N and Mölnlycke. Advanced Dressings, the workhorse of Advanced Wound Care, accounts for 52.3% of WW revenues, up +3.3% YoY. Skin/Dermal Substitute (CTP) revenue was up +10.7% YoY, lower than previous years, but still double-digit gains. WW NPWT was up +4.3% YoY, with traditional devices having a slight uptick and single-use driving the increase of +28.9%.

Among the many topics covered in the Q418/FY18 Advanced Wound Care Market Recap are:

Topics: Wound Care
Continue Reading
1 min read

S&N Solidifies its Leadership Position in Wound Biologics

By Susan Paquette on 4/15/19 12:00 PM

S&N plans to shore up its Advanced Wound Bioactives business with the acquisition of Osiris Therapeutics but the deal may be in question as Osiris shareholders challenge the price.

 Smith & Nephew (S&N) announced on March 12, 2019 that it has agreed to acquire Osiris Therapeutics for $660MM with the deal expected to close Q219. However, the deal could be in question as a group of Osiris shareholders is suing to block the acquisition. The lawsuit disputes Cantor Fitzgerald’s discounted cash flow analysis, saying it does not adequately reflect Osiris’s future growth prospects, and is based on growth rates that are about half of what Osiris has experienced in recent years, resulting in a valuation that is too low. The acquisition would add the Osiris’s Grafix and Stravix product lines to S&N’s ailing Advanced Wound Bioactives portfolio. If allowed to proceed, the acquisition would solidify S&N’s leadership in wound biologics and changes the competitive landscape in the Advanced Wound Care market.

Topics: Wound Care
Continue Reading
3 min read

Q418/FY18 Market Recap: US Hemostats and Sealants

By Doug Devens on 4/9/19 1:39 PM

The US market for Hemostats and Sealants accelerated in Q418 driven by growth in fibrin sealants and thrombin hemostats, overcoming slow growth during the first half of the year.

The US market for Hemostats and Sealants accelerated with +9.3% YoY growth in Q418, continuing to build on its +7.9% YoY in Q318, with fibrin sealants and thrombin hemostats driving the increase. The US market grew +6.1% in FY18, overcoming slow growth during the first half of the year.

As reported in SmartTRAK Financial Dashboard, every manufacturer in the Hemostats and Sealants market, except Pfizer and CryoLife, experienced revenue growth in Q418. Leading the way was Baxter with +33.1% YoY growth as it made progress with its integration of the Mallinckrodt portfolio. Ethicon and Becton Dickinson (BD) both posted solid gains, with +8.7% YoY and +6.6% YoY growth, respectively...

Topics: Wound Care
Continue Reading
5 min read

Q418/FY18 Market Recap: SCS Market Slows

By Anne Staylor on 4/9/19 10:12 AM

The Spinal Cord Stimulation (SCS) market saw high-teens growth in FY18, but decelerated in Q418.

The US SCS Market saw another banner year in FY18, growing +17.4% YoY. Market growth was driven by new product launches, expanding indications and ongoing demand for non-narcotic alternatives that address chronic intractable pain and the opioid epidemic.

Continue Reading
4 min read

SmartTRAK's Q418/FY18 OrthoBio Market Recap

By Kim French on 4/8/19 2:00 PM

Advanced, higher priced biologics push the US OrthoBio Market higher

Based on Q418/FY18  SmartTRAK Financial Dashboard reporting:
  • US Bone Replacement grew +2.3% YoY, with FY18 revenues up +2.7%.
  • US Cartilage Replacement increased 55.7% YoY, with FY18 revenues up 34.7%.
  • US Soft Tissue Augmentation grew 2.3%, with FY18 revenues growing 9.2%.
  • US Tendon Allografts posted an 8.4% YoY increase, with FY18 revenues up +3.9% YoY
  • US Meniscal Implant market, with robust growth, was up 15.6% YoY for Q418 with FY18 revenues increasing by 3.0%.

Among the many topics covered in the Q418/FY18 OrthoBio Market Recap are:

Topics: Orthopedics
Continue Reading
1 min read

SmartTRAK Cited in Smith & Nephew Osiris Acquisition Press Release

By Susan Paquette on 4/8/19 10:13 AM

SmartTRAK was cited as a source in a press release from Smith & Nephew entitled "Smith & Nephew expands in high growth regenerative medicine market through acquisition of Osiris Therapeutics, Inc."

Topics: Wound Care
Continue Reading
3 min read

Q418/FY18 Market Recap: US Surgical Matrices

By Doug Devens on 4/5/19 9:45 AM

The US Surgical Matrices Market continued to advance in Q418, driven by a resurgence of Becton Dickinson in hernia matrices and continued growth of breast matrices.  The US market grew +9.7% in FY18.

SmartTRAK reports that the US Surgical Matrices market grew in both the Breast and Hernia Repair segments. SmartTRAK estimates the Breast segment grew again at +21.8% YoY growth to 35.2% share of the entire Surgical Matrices market. The Hernia Repair market continued its recovery up +4.8% YoY and 64.8% share of the US Surgical Matrices Market in Q418.  

Among the many topics covered in the Q418/FY18 Surgical Matrices Market Recap are:

Topics: Wound Care
Continue Reading
3 min read

Q418/FY18 Infection Prevention: Vascular Access Adjunct Products

By Susan Paquette on 4/3/19 11:25 AM

FY18 showed solid gains in all segments, up +5.7% YoY, as antimicrobial devices take the lead.

Topics: Wound Care
Continue Reading
4 min read

SmartTRAK's Q418/FY18 Spine Market Recap

By Julianne Burns on 4/1/19 12:28 PM

Q418 US Spine market remains fairly flat, rounding out a stable but unremarkable FY18.

SmartTRAK’s Financial Dashboard indicates a fairly flat Q418 US Spine market, with a decline of -0.4%. Similarly, for the full year, the US Spine Market was stable, with +0.9% growth. WW revenues increased modestly with a +1% uptick for FY2018. Spine market growth as a whole slowed sequentially to +1% in Q418 from +2% in Q3 according to estimates. Growth continues to be restricted in the US Spine market by a few key factors. Payer pushback is the norm, and while most surgical practices have learned to deal with it, the environment is ever-changing with new obstacles and hurdles.

Among the many topics covered in SmartTRAK's Q418/FY18 Spine Market Recap are:

Topics: Orthopedics
Continue Reading
2 min read

Customize Your SmartTRAK Updates Email!

By Lindsey Wolejko on 3/31/19 6:55 PM

SmartTRAK Subscribers: See only news for the Markets, Modules and Segments and TYPES of content that you care about!

Have you ever wished that you could customize your SmartTRAK Daily Updates Email so that you can see ONLY news about the SmartTRAK Markets, Modules & Segments as well as Type of content that you care about (like skipping all the Patent updates)?

And that you could save yourself time from scrolling through all the Markets, Modules and Segments that your company subscribes to? 

Continue Reading
3 min read

Q418/FY18 Extremities Market Recap

By Lisa Mahan on 3/25/19 8:03 PM

Pricing pressure and tough comps slow year end growth

SmartTRAK reports that pricing pressure and a slow down in elective procedures impacted the Extremities market overall, with US Market growth down sequentially from +4.7% seen in Q318 to +3.5% in Q418. The Extremities market no longer seems to be able to fly under the radar and, as healthcare facilities look to maximize reimbursement in all areas, pricing for legacy products are facing discounting. In addition to pricing pressure, economic uncertainty in the US during Q4 led to some healthcare consumers choosing to put off elective procedures...

Among the many topics covered in the Q418/FY18 Extremities Market Recap:

Topics: Orthopedics
Continue Reading
8 min read

What’s New and What’s Next in Advanced Wound Care

By Susan Paquette on 3/25/19 10:52 AM

Following the last fall's Advanced Wound Care meeting, SmartTRAK's Susan Paquette, VP Wound, reported on advances in negative pressure wound therapy (NPWT), fiber dressings and human dermal tissue and the latest research and company news, identifying what’s new and what’s next in the market for advanced wound care.

Topics: Wound Care
Continue Reading
3 min read

Q418/FY18 Joint Fluid Market Recap

By Freddy Buntoum on 3/18/19 12:45 PM

Revenues down again, owing to intense competitive pricing pressures

Pricing pressure continued to negatively impact the US Joint Fluid market, which experienced a decline of -7.9% based on Q418 revenues according to SmartTRAK Financial Dashboard. While this market continued to see unit volume increases, ASPs experienced notable declines over the past four quarters as a result of several companies not listing ASPs to CMS, which fueled competitive pricing. Additionally, revenues were impacted by the Anthem non-coverage decision that took effect in Q118 and kept impacting suppliers over the course of the year...

Among the many topics covered in the Q418/FY18 Joint Fluid Market Recap:

Topics: Orthopedics
Continue Reading
3 min read

Q418/FY18 TJR Market Recap: Not Your Typical Rebound

By Lisa Mahan on 3/14/19 1:03 PM

Typically, Q4 is a rebound quarter for Total Joints, but SmartTRAK reports that the Q418 US market experienced a sequential decline in growth from Q318’s unseasonably strong growth, due in part to easier YoY comps. In addition, Q4 growth was also slower than the same period last year. FY18 results for the US TJR market confirms a slowing in revenue growth compared to FY17. SmartTRAK believes that increased pricing pressure and a deceleration in procedure volumes during Q4 contributed to the lower growth...

Topics: Orthopedics
Continue Reading
10 min read

Computer Assisted Surgery Takes Center Stage

By Elise Wolf on 3/7/19 10:00 AM

01With the upcoming orthopedic conference season upon us, we thought it would be interesting to take a look back at a fascinating article written by Elise Wolf, Senior Analyst, Computer Assisted Surgery, from NASS 2108, discussing the future of robotics and other enabling technologies that created a buzz on the exhibit floor.

NASS 2018: New Technology in Computer-Assisted Surgery Takes Center Stage
Robotics, navigation and other enabling technologies were hot topics at the North American Spine Society’s (NASS) 33rd annual meeting, held September 25-28, 2018 in Los Angeles, CA. Manufacturers are developing a variety of computer-assisted surgery (CAS) technologies for spine surgery, including surgical planning systems, navigation systems, robotics, augmented reality (AR) technology and artificial intelligence (AI). While growth in the fusion market has slowed over the past few years due to pricing pressure, reduced procedure volumes and reimbursement non-coverage, robotic and other CAS technologies have offered means for growth...

Download a PDF of Elise Wolf's NASS 2018 CAS Article now!

Topics: Orthopedics
Continue Reading
4 min read

Extremities Trends: 2019 and Beyond

By Lisa Mahan on 2/28/19 3:00 PM

SmartTRAK highlights trends shaping the Extremities Market

It’s no surprise orthopedic companies continue to focus on the Extremities market. Extremities has delivered overall growth in the US in the high single digits – above 6% for nearly all of 2018, according to SmartTRAK Financial Dashboard, and this growth trend is expected to extend through 2019.

So what else is influencing the Extremities market? Here are some trends to watch:

Topics: Orthopedics
Continue Reading
2 min read

Growth Amid Debate: Open vs Robotic Techniques for Inguinal Hernia Repair

By Doug Devens on 2/26/19 8:00 AM

Doug Devens, SmartTRAK's Senior Analyst, Biosurgery wrote a fascinating article titled "Growth Amid Debate: Open vs Robotic Techniques for Inguinal Hernia Repair", in which he shines a light on issues and trends in robotic surgery and the market for inguinal hernia matrices.

Continue Reading
3 min read

SmartTRAK Start-Up Spotlight: OrthoXel

By Tim Jeavons on 2/21/19 1:30 PM

OrthoXel is an orthopaedic trauma device company focused on evolving fracture fixation through evidence-based biomechanical implant design. The Company thoughtfully designed its flagship Apex Tibial and Femoral Nails with a focus on fundamental principles of bone healing, all while keeping the surgeon’s needs in mind. Every OrthoXel product features innovative locking modes not found in any other implant system on the market and all are meticulously designed and engineered to produce the best possible clinical results for every patient.  

Topics: Orthopedics
Continue Reading
2 min read

Meet Our VP of Orthopedics at AAOS

By Sharon O'Reilly on 2/18/19 12:34 PM

Will you be attending AAOS this year? SmartTRAK will be exhibiting (booth #6847) and we’re hoping to schedule a quick meeting to check-in with you and learn how we can better meet your needs. 

We’ll also have several SmartTRAK analysts on-site consulting with customers. Have questions about market numbers or want to know more about the latest technologies on the market? Maybe you have some questions about our latest market recap or where the market is going?

Topics: Orthopedics
Continue Reading
5 min read

Advanced Therapies: SmartTRAK Interviews  Robert Keller, CSO of Axolotl Biologix

By Kim French on 2/12/19 10:57 AM

Stem cell “secretome” is the latest advancement in regenerative medicine. Will it become the heart of tissue regeneration? SmartTRAK interviewed Dr. Robert Keller, Ph.D, Chief Science Officer of Axolotl Biologix to learn more about the Company’s platform and future plans.

The core of regenerative medicine and leveraging the abilities of stem cells and their products to repair diseased or damaged tissues has focused in two main areas, harvesting progenitor cells and the “paracrine effect” of the stem cell secretome.

Recent studies suggest that the benefits of stem cell therapy and the underlying mechanism of repair might relate more to a paracrine modulatory effect rather than the replacement of damaged cells at the site. The secreted factors from the transplanted stems cells have been shown to trigger the patient's own cells to repair the tissue themselves.

One company that is harnessing the power of the stem cell secretome is Axolotl Biologics. Started in 2016, Axolotl Biologics offers human amnion-derived mesenchymal stromal cell (hAMSCs) conditioned medium that contains hAMSCs paracrine factors which can be used in various applications in orthopedics, wound care, pain management, ophthalmology, cardiovascular and cosmetics.

At the 6th ICRS Summit, Bio-Orthopaedics in Sports Medicine, held in San Diego, January 17 and 18, 2019, SmartTRAK caught up with Axolotl Biologix’ Chief Science Officer, Robert Keller, Ph.D. to discuss regenerative medicine and the Company’s progress.

Click on the video below to view the fascinating interview,  scroll down to read a transcript of the interview or download a PDF of the interview by clicking the link below.

Topics: Orthopedics
Continue Reading
1 min read

Meet SmartTRAK's Freddy Buntoum - Sr. Analyst, Regenerative Medicine

By Sharon O'Reilly on 2/4/19 11:14 AM

Frederique Buntoum (aka Freddy) has joined BioMedGPS as Senior Analyst, Regenerative Medicine, overseeing the Cell Processing, Amniotic Tissue and Joint Fluid modules. Formerly Senior Manager of Market Insights at Bioventus, Freddy has broad experience in sales, marketing and competitive intelligence. Her passion for market research and uncovering the “why” behind industry developments complements SmartTRAK’s team of domain experts and her thoughtful and keen insights and out-of-the-box perspective on market happenings make her a great addition to the SmartTRAK analyst team.

In addition to her role as an analyst, Freddy will also be assisting with consulting projects and product development initiatives – two key areas that will contribute to BioMedGPS growth in 2019.

Freddy will be representing SmartTRAK at the upcoming AAOS meeting. Please Contact us if you would like to set up a time to meet.

Continue Reading
2 min read

SmartTRAK attending International Stroke Conference 2019

By Anne Staylor on 1/23/19 10:24 AM

SmartTRAK is excited to be attending the AANS/CNS Joint Cerebrovascular Annual Meeting on Feb. 4-5, 2019 at the Sheraton Waikiki in Honolulu, Hawaii and the International Stroke Conference 2019, Feb 6-8, also in Honolulu.

Anne Staylor, Managing Editor, Business Intelligence and Senior Director, Advanced Technologies will be representing BioMedGPS SmartTRAK at both conferences. Please Contact Usif you would like a meeting!

Continue Reading
3 min read

Q318 SCS Market Recap: On Track for Another Record Year

By Anne Staylor on 1/21/19 10:17 AM

New Products, Continued Demand Provide SCS Market Tailwinds

SmartTRAK reports that with new products providing a strong tailwind in Q318, the SCS market saw another quarter of strong double-digit growth in both the US and WW, positioning the market for another record year. 

Among the many topics covered in the Q318 SCS Market Recap are:

Continue Reading
2 min read

Strong Q318 for Soft Tissue Fixation: SmartTRAK Market Recap

By Kristina Meyer on 1/18/19 9:30 AM

Well-rounded portfolios leading to strong Q318 for Soft Tissue Fixation

SmartTRAK reports that the continued rounding out of portfolios is leading to some commoditization in the market, but also allowing companies to capitalize on the strength of their sales forces in new portions of the Sports Medicine Market. High single and double-digit growth reported...

Among the many topics covered in the Q318 Soft Tissue Fixation Market Recap are:

Topics: Orthopedics
Continue Reading
9 min read

SmartTRAK Spotlight: SUTUREGARD Medical

By Don Urbanowicz on 1/16/19 10:13 AM

SUTUREGARD is on a mission to close more wounds simply and safely

SmartTRAK Spotlights SUTUREGARD medical, a privately held medical device firm with patented technology that allows surgeons to perform simple closures of high-tension wounds through rapid intraoperative tissue expansion.

Company Overview

Founded in 2015 and based in Portland, Oregon, SUTUREGARD™ Medical, Inc. is a privately held medical device firm with patented technology that allows surgeons to perform simple closures of high-tension wounds through rapid intraoperative tissue expansion. For skin cancer surgeons (Mohs Surgeons), SUTUREGARD’s initial target market, the SUTUREGARD™ device allows closure of wounds using tissue expansion instead of relying on flaps, grafts, or second intent healing. This is particularly useful for scalp and lower leg closures. For some skin cancer surgeons, this will add greater efficiency to their day. For other skin cancer surgeons, this will retain closures in their practice that they would have otherwise sent to other specialists.

The Company founders — a Corvallis, Oregon-based skin cancer (Moh’s) surgeon and his Ph.D. nurse business partner — designed the SUTUREGARD device. The Company invested three years conducting bench research, pre-clinical studies, and customer discovery prior to completion of a successful human use study in 2018.

“SUTUREGARD Medical launched the SUTUREGARD device in November, 2018 at the Fundamentals of Mohs Surgery Conference and the product was enthusiastically received by surgeons.”   Dan Ladizinsky, MD, CEO of SUTUREGARD Medical.

Topics: Wound Care
Continue Reading
2 min read

Spinal Cord Stimulation: Top Trends to Watch in 2019 and Beyond

By Anne Staylor on 1/15/19 12:00 PM

SmartTRAK identifies trends to watch in spinal cord stimulation 

With the start of a new year, it's time to look back at 2018 and identify continuing and emerging trends in the market for Spinal Cord Stimulation (SCS) that are likely to shape the landscape in 2019 and beyond.

So what’s on the horizon? Anne Staylor, SmartTRAK Managing Editor, gives her predictions for the top technology and market trends to watch.

Among the many interesting and informative topics covered in the article are:

Continue Reading
2 min read

NANS 2019 Preview: SmartTRAK Interviews Todd Sitzman, MD

By Anne Staylor on 1/14/19 10:00 AM

In an interview with SmartTRAK, B. Todd Sitzman, MD, MPH, President of the North American Neuromodulation Society (NANS), provides a preview of the educational opportunities, key research and emerging technologies that will be at the NANS 22nd Annual meeting to be held January 17-20, 2019 in Las Vegas, NV. Dr. Sitzman expects NANS 2019 to be the biggest meeting yet for the premier neuromodulation society, with up to 3000 attendees and 300+ abstracts presented, organized around the theme of “The Science Behind Successful Outcomes.”

To find out more about the meeting, click on the video below to listen to SmartTRAK’s interview with Dr. Sitzman, recorded via Skype from his office in Hattiesburg, Mississippi (11:53 minutes). 

Continue Reading
3 min read

Q318 CAS Ortho Market Recap: Robotics Contribute to Above Market Growth

By Elise Wolf on 1/11/19 11:55 AM

Robotics Contributing to Above Market Growth Through Implant Pull-Through

Robotics continued to be a hot topic in orthopedics in Q318 with some companies and surgeons projecting that robotics will become standard-of-care in orthopedic procedures in the next 3-5 years...

Among the many interesting topics covered in SmartTRAK's Q318 CAS Ortho Market Recap are:

Topics: Orthopedics
Continue Reading
3 min read

Q318 CAS Spine Market Recap: Medtronic Leads Market in Robotics

By Elise Wolf on 1/10/19 9:30 AM

Spine robotics was a hot topic throughout Q318, culminating at the NASS meeting in September.

SmartTRAK reports that with increasing adoption of spine robotic systems and potential expanded indications beyond pedicle screw placement on the horizon, market leader Medtronic believes that robotics will expand from ~5% of procedures in the US today to reach up to...

Among the many interesting topics covered in SmartTRAK's Q318 CAS Spine Market Recap are:

Continue Reading
3 min read

Q318 Extremities Market Recap: Increased Pricing Pressure

By Natasha Weeks on 1/9/19 9:30 AM

Extremities Fixation decelerates as shoulder replacements remain strong

Q318 WW Extremities Market growth declined sequentially to +3.7%, compared to +6.2% growth in Q2. Steeper growth slowdowns in the fixation market segments – Upper Extremities Fixation at +1.8% and Foot & Ankle Fixation at +1.4% - were due in part to...

Among the many topics covered in SmartTRAK's Q318 Extremities Market Recap are:

Topics: Orthopedics
Continue Reading
3 min read

Q318 Trauma Market Recap: Pricing Pressure Impacts Growth

By Natasha Weeks on 1/8/19 2:31 PM

Tough comps, supply disruption and the ever-present pricing pressure impacts growth

SmartTRAK reports that the WW Trauma Market experienced a downturn in Q3, posting only +1.1% (reported) growth. The US Market was up +2.0% YoY, but is down sequentially compared to last quarter’s +5.0% gains...

Among the many topics covered in SmartTRAK's Q318 Trauma Market Recap are:

Topics: Orthopedics
Continue Reading
3 min read

Q318 Market Recap: US Surgical Matrices

By Doug Devens on 1/8/19 9:30 AM

The US Surgical Matrices Market continued to advance in Q318, up +10.3% YoY, fueled by continued rapid adoption of allograft breast matrices and the resurgence of synthetic hernia matrices.

According to BioMedGPS’ SmartTRAK Financial Dashboard, in Q318, the US Surgical Matrices Market grew +10.3% YoY. The allograft breast matrices and biosynthetic hernia matrices segments outpaced overall market growth, as both posted...

Among the many interesting topics covered in the Q318 US Surgical Matrices Market Recap are:

Continue Reading
3 min read

Q318 Infection Prevention: Vascular Access Adjunct Products Market Recap

By Susan Paquette on 1/4/19 9:30 AM

Growth continues for another quarter as market leaders gain more share.

For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY.

Among the many topics covered in the Q318 Infection Prevention Market Recap are:

Topics: Wound Care
Continue Reading
3 min read

Q318 US Hemostats and Sealants Market Recap

By Doug Devens on 1/3/19 12:00 PM

The US market for Hemostats and Sealants accelerated substantially in Q318 vs Q218

As reported in SmartTRAK’s Financial Dashboard, every manufacturer in the Hemostats and Sealants market, with the exception of Pfizer, saw revenue growth in Q318. Leading the way were Baxter, with its integration of the Mallinckrodt portfolio, as well as Ethicon and Integra, while Pfizer posted...

Among the many topics covered in the Q318 US Hemostats and Sealants Market Recap are:

Topics: Wound Care
Continue Reading

    Recent Articles